vancomycin has been researched along with imipenem, anhydrous in 239 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 18 (7.53) | 18.7374 |
| 1990's | 77 (32.22) | 18.2507 |
| 2000's | 70 (29.29) | 29.6817 |
| 2010's | 54 (22.59) | 24.3611 |
| 2020's | 20 (8.37) | 2.80 |
| Authors | Studies |
|---|---|
| Chu, DT; Katz, L; Plattner, JJ | 1 |
| Blizzard, TA; Cama, LD; DiNinno, FP; Dorso, KL; Dykstra, KD; Hammond, GG; Hammond, ML; Heck, JV; Kohler, J; Ratcliffe, RW; St Rose, E; Wildonger, KJ; Wilkening, RR | 1 |
| Blizzard, TA; Dorso, KL; Hammond, GG; Hammond, ML; Heck, JV; Huber, J; Kohler, J; May, WJ; Morgan, JD; Parker, DL; Ratcliffe, RW; Santorelli, GM; St Rose, E; Sundelof, JG; Waddell, ST; Wildonger, KJ; Wilkening, RR | 1 |
| DiNinno, F; Greenlee, ML; Herrmann, JJ; Jaworsky, C; Muthard, DA; Salzmann, TN | 1 |
| DiNinno, F; Greenlee, ML; Huber, JL; Laub, JB; Sundelof, JG | 1 |
| DiNinno, F; Greenlee, ML; Hammond, GG; Hammond, ML; Huber, JL; Laub, JB; Rouen, GP; Sundelof, JG | 1 |
| Cho, A; Fan, AT; Glinka, TW; Hecker, SJ; Ludwikow, M; Wang, M | 1 |
| Angehrn, P; Buchmann, S; Funk, C; Gmuender, H; Goetschi, E; Hebeisen, P; Kostrewa, D; Link, H; Luebbers, T; Masciadri, R; Nielsen, J; Reindl, P; Ricklin, F; Schmitt-Hoffmann, A; Theil, FP | 1 |
| Cirioni, O; Della Vittoria, A; Giacometti, A; Kamysz, W; Licci, A; Okroj, M; Scalise, G; Silvestri, C | 1 |
| Cirioni, O; Della Vittoria, A; Giacometti, A; Kamysz, W; Nadolski, P; Riva, A; Scalise, G; Silvestri, C; Łukasiak, J | 1 |
| Bradbury, BJ; Buechter, DD; Cheng, J; Deshpande, M; Mushtaq, G; Podos, SD; Pucci, MJ; Thanassi, JA; Thoma, CL; Vigliotti, GA | 1 |
| Kwon, DH; Lu, CD | 1 |
| Atsumi, K; Iwamatsu, K; Kano, Y; Kurazono, M; Maruyama, T; Matsuhisa, E; Shitara, E; Takata, H; Takata, T; Yamamoto, Y | 1 |
| Fritsche, TR; Jones, RN; Sader, HS | 1 |
| Higashide, M; Ichimura, S; Kumano, M; Kuroda, M; Ohkawa, S; Ohta, T; Omura, CT | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Biek, D; Ge, Y; Sahm, DF; Talbot, GH | 1 |
| Camargo, IL; Cui, L; Hiramatsu, K; Neoh, HM | 1 |
| Jacobus, NV; McDermott, LA; Snydman, DR | 1 |
| Bradford, PA; Jones, CH; Mansour, TS; Petersen, PJ; Projan, SJ; Venkatesan, AM | 1 |
| Atsumi, K; Iwamatsu, K; Kano, Y; Kurazono, M; Maruyama, T; Shitara, E; Yamamoto, Y | 1 |
| Cui, L; Hiramatsu, K; Neoh, HM; Shoji, M | 1 |
| Cui, L; Hiramatsu, K; Katayama, Y; Murakami-Kuroda, H | 1 |
| Brunner, LS; Haas, W; Lee, JC; Morris, TW; Pillar, CM; Zurenko, GE | 1 |
| Schaadt, R; Shinabarger, D; Sweeney, D; Zurenko, G | 1 |
| Cartabuke, RH; Nguyen, HT; Nguyen, L; Ogwang, S; Singh, A; Wolff, KA | 1 |
| Bunders, C; Huigens, RW; Melander, C; Reed, CS; Reyes, S; Rogers, SA; Steinhauer, AT | 1 |
| Chen, HC; King, CH; Lai, JF; Lauderdale, TL; Shiau, YR | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Bajaksouzian, S; Biek, D; Critchley, IA; Good, CE; Jacobs, MR; Jones, RN; Sader, HS; Windau, AR | 1 |
| Chong, Y; Jeong, SH; Kim, MS; Lee, K; Lee, Y; Park, Y; Yong, D | 1 |
| Bavari, S; Bowlin, TL; Butler, MM; Moir, DT; Panchal, RG; Peet, NP; Shinabarger, DL; Williams, JD | 1 |
| Angehrn, P; Gmuender, H; Goetschi, E; Hebeisen, P; Hennig, M; Kuhn, B; Luebbers, T; Reindl, P; Ricklin, F; Schmitt-Hoffmann, A | 1 |
| Koyama, N; Takahashi, Y; Tokura, Y; Tomoda, H | 1 |
| Cabanillas, AH; Maderuelo Corral, S; Martel Quintana, A; Ortega Doménech, M; Rosero Valencia, DF; Rumbero Sánchez, Á; Tena Pérez, V | 1 |
| Ba, Z; Chang, L; Gou, S; Li, B; Liu, H; Ni, J; Ouyang, X; Zhang, J; Zhang, T; Zhang, Y; Zhong, C; Zhu, N; Zhu, Y | 1 |
| Guo, Y; Jia, G; Li, L; Wang, J; Wei, L; Xu, X; Yang, Y; Yu, Q; Zhou, Y | 1 |
| Hanberger, H | 1 |
| Anwar, N; Gokal, R; Merchant, MR; Tooth, JA; Uttley, L; Were, A | 1 |
| Lenz, W; Machka, K; Milatovic, D; Voss, A | 1 |
| Inamatsu, T | 1 |
| Bosseray, A; Brion, JP; Hollard, D; Michallet, M; Micoud, M; Nicolini, F; Stahl, JP | 1 |
| Barakett, V; Burghoffer, B; Delisle, F; Guidet, B; Lesage, D; Offenstadt, G; Petit, JC; Richard, G; Vergez, P | 1 |
| Shimada, K | 1 |
| Clave, D; Leophonte, P; Massip, P; Moatti, N; Rouquet, RM | 1 |
| Arning, M; Aul, C; Chlebowski, H; Gehrt, A; Hadding, U; Schneider, W; Wolf, M | 1 |
| Riikonen, P | 1 |
| Berenguer, J; Bouza, E; Ena, J; Peláez, T | 1 |
| Barnass, S; Holland, K; Tabaqchali, S | 1 |
| Matsumoto, K; Nagatake, T | 1 |
| Barr, JG; Hogg, GM; Smyth, ET | 1 |
| Barranco, EA; Gilligan, PH; Ritz, WJ; Schwalbe, RS; Verma, PR | 1 |
| Fuursted, K | 2 |
| Dehne, M; el Abed, K; Hofmann, W; Kroh, U; Lennartz, H | 1 |
| Brauner, E; Davey, P; Gorbach, S | 1 |
| Traub, WH | 1 |
| Klastersky, J; Van der Auwera, P | 1 |
| Bauer, D; Spohr, M; Traub, WH | 2 |
| Gottschall, S; Kim, MJ; Randall, EL; Weiser, M | 1 |
| Matthews, J; Newsom, SW; Rampling, AM | 1 |
| Fernandez-Guerrero, M; Henry, N; Rouse, M; Wilson, W | 1 |
| Chandrasekar, PH; Levine, DP; Price, S; Rybak, MJ | 1 |
| Archer, GL; Berry, AJ; Johnston, JL | 1 |
| Durgham, SM; Ishag, AJ; Shibl, AM | 1 |
| Klastersky, J; Van der Auwera, P; Van Laethem, Y | 1 |
| Chambers, HF; Hackbarth, C; Sachdeva, M; Stella, FB | 1 |
| Breyer, S; Francesconi, M; Georgopoulos, A; Graninger, W; Leitha, T; Lenz, K | 1 |
| Aznar, J; García Iglesias, MC; Perea, EJ | 1 |
| Erlendsdóttir, H; Gottfredsson, M; Gudmundsson, A; Gudmundsson, S | 1 |
| Carbon, C; Cochereau, I; Marrakchi-Benjaafar, S; Pocidalo, JJ | 1 |
| Diaz, E; Garcia-Curiel, A; Infante, P; Lopez, JD; Muñoz, M; Silva, JJ; Soult, JA; Valderrabanos, ES | 1 |
| Anwar, N; Gokal, R; Merchant, M; Tooth, A; Uttley, L; Were, T | 1 |
| Delia, S; Iona, E; Mascellino, MT; Mastroianni, CM; Ponzo, R | 1 |
| Freifeld, AG; Gill, V; Gress, J; Hathorn, J; Jarosinski, P; Marshall, D; Rubin, M; Steinberg, SM; Walsh, T; Young, RC | 1 |
| Echávarri, B; Marco, ML; Remacha, A | 1 |
| Daenen, SM; de Vries-Hospers, HG; Erjavec, Z; Halie, MR; van der Waaij, D; van Kamp, H | 1 |
| Chuard, C; Lew, DP; Rohner, P; Schaad, HJ; Vaudaux, P; Waldvogel, FA | 1 |
| Pepe, R; Wood, CA | 1 |
| Bressolle, F; de la Coussaye, JE; Eledjam, JJ; Galtier, M; Kinowski, JM; Wynn, N | 1 |
| Deguchi, K; Fukayama, S; Ishihara, R; Koguchi, M; Oda, S; Suzuki, Y; Yokota, N | 1 |
| García, D; Javaloyas, M; Ruffi, G | 1 |
| Deguchi, K; Fukayama, S; Ishihara, R; Koguchi, M; Suzuki, K; Suzuki, Y; Yokota, N | 1 |
| Freifeld, AG | 1 |
| Eppes, SC; Klein, JD | 1 |
| Budka, H; Halonen, P; Kalimo, H; Marttía, R; Nikoskelainen, J; Oksi, J; Peltonen, R; Salomaa, P; Viljanen, MK | 1 |
| Brandt, CM; Laue, NW; Rouse, MS; Steckelberg, JM; Stratton, CW; Wilson, WR | 1 |
| Abi-Said, D; Bodey, GP; Ghaddar, HM; Hachem, RY; Karl, CL; Pandya, RG; Raad, II; Rolston, KV; Whimbey, EE | 1 |
| Antony, SJ; Matherin, P; Stratton, C | 1 |
| Nakagawa, Y; Toyoguchi, T | 1 |
| Maezawa, H; Nakazawa, Y; Saitoh, A; Sakai, O; Sakamoto, M; Saruta, K; Shiba, K; Shindo, N; Yoshida, M; Yoshikawa, K | 1 |
| Nakagawa, Y; Toyoguchi, T; Watanabe, H | 1 |
| Hatori, T; Matsumoto, T; Miyazaki, H; Takashima, K; Tateda, K; Yamaguchi, K | 1 |
| Choi, YJ; Hong, T; Kish, A; Millett, W; Ndamukong, J; Win, KK | 1 |
| Appelbaum, PC; Jacobs, MR; Visalli, MA | 1 |
| Alfaro, DV; Bevin, AA; Hudson, SJ; Laughlin, RM; Mines, M; offele, JJ; Schoderbek, RJ | 1 |
| Corps, CM; Denton, M; Hawkey, PM; Kerr, KG; Kumari, P; Todd, N | 1 |
| Abi-Said, D; Bodey, G; Raad, I; Rolston, K; Whimbey, E | 1 |
| Cuschieri, P; Galizia, AC; Vassallo, J | 1 |
| Hanberger, H; Nilsson, LE; Svensson, E | 1 |
| Arranz, R; Cámara, R; del Rey, MC; Fernández-Rañada, JM; Figuera, A; Hernández, L; Jiménez, ML; López-Lorenzo, JL; Peñarrubia, MJ; Tomás, JF | 1 |
| Archibald, L; Gaynes, R; McGowan, JE; Monnet, D; Phillips, L; Tenover, F | 1 |
| Sakamoto, M | 1 |
| Cabibbo, E; Corulli, M; Dima, F; Fallacara, C; Longo, M; Peroni, L; Pizzi, R; Pollara, PC; Ravizzola, G; Turano, A | 1 |
| Palmer, SM; Rybak, MJ | 1 |
| Fujita, Y; Fukabori, T; Mizobuchi, K; Nakamura, M; Takashina, R; Takizawa, H | 1 |
| Aikawa, N; Denno, R; Fujimoto, M; Hirata, AK; Ishibiki, K; Ishihara, R; Ishikawa, S; Iwai, S; Kinoshita, H; Koide, H; Kunimatsu, M; Manabe, T; Mashita, K; Mizuno, A; Morimoto, K; Mukaiya, M; Ohnishi, H; Ohtsuka, K; Sakaguchi, S; Shinagawa, N; Takuma, K; Tanimura, H; Umemoto, Y; Ushijima, Y; Yura, J | 1 |
| Archer, GL; Climo, MW; Hale-Cooper, CG; Markowitz, SM; Williams, DS | 1 |
| Akram, S; Campos, JM; Donkersloot, JA; Keith, JM; Pikis, A; Rodriguez, WJ | 1 |
| Asano, K; Fuse, A; Hashizume, T; Nagano, R; Naito, T; Nakagawa, S; Shibata, K | 1 |
| Adachi, Y; Hashizume, T; Hazumi, N; Kato, Y; Nakagawa, S; Nakamura, K | 1 |
| Cheadle, WG; Fabian, T; Fry, DE; Gardner, SA; Kesterson, L; Livingston, DH; Malangoni, MA; Polk, HC; Trachtenberg, LS | 1 |
| Kimpara, I; Kudo, E; Kudo, H; Kudo, Y; Miura, T; Saitoh, Y; Sato, S; Tsujino, M | 1 |
| Cetron, MS; Crane, GL; Finelli, L; Jarvis, WR; Paul, SM; Tokars, JI | 1 |
| Casali, A; Della Giulia, M; Di Lauro, L; Gionfra, T; Santini, S; Sega, FM; Vici, P | 1 |
| Benali, K; Bingen, E; Bonacorsi, S; Doit, C; Fitoussi, F; Geslin, P | 1 |
| Antony, SJ; Dummer, SJ; Ladner, J; Raudales, F; Stratton, CW | 1 |
| Hashimoto, Y; Inui, KI; Kokuryo, T; Nakamura, T | 2 |
| Collatz, E; Gutmann, L; Mainardi, JL; Rybkine, T; Sougakoff, W | 1 |
| Barbé, G; Bertrand, Y; Philippe, N; Ploton, C; Pondarré, C; Souillet, G | 1 |
| Igari, J; Nakamura, A; Oguri, T; Tabe, Y | 1 |
| Akiyama, H; Arata, J; Kanzaki, H; Tada, J; Yamasaki, O | 1 |
| Cristofori, P; Di Modugno, E; Ladel, CH; Lanzoni, A; Marzola, P; Nicolato, E; Sbarbati, A | 1 |
| Kikuchi, K; Matsui, Y; Shiseki, M; Totsuka, K | 1 |
| Adachi, Y; Hashizume, T; Imamura, H; Morishima, H; Nagano, R; Shibata, K | 1 |
| Barbarini, D; Carretto, E; Emmi, V; Marone, P; Marzani, FC; Poletti, F | 1 |
| Fukuhara, J; Homma, S; Kouda, M; Takeuchi, M; Tamura, K; Udagawa, I | 1 |
| Asencio, MA; Blanco, J; Carro, J; Garduño, E; Pascasio, JM; Rebollo, M | 1 |
| Alter, P; Maisch, B; Schaefer, JR | 1 |
| Fridkin, SK; Gaynes, RP; Hubert, SK; Lawton, R; McGowan, JE; Steward, CD; Tenover, FC; Wallace, D | 1 |
| Barchiesi, F; Cirioni, O; Giacometti, A; Scalise, G | 1 |
| Dieleman, LA; Freitag, R; Li, F; Linde, HJ; Rath, HC; Sartor, RB; Schölmerich, J; Schultz, M | 1 |
| Frangié, C; Grenier, N; Lacut, JY; Morel, D; Pariente, JL; Potaux, L; Sassoust, G | 1 |
| Weinstein, MP | 1 |
| Abe, T; Fukuoka, T; Inoue, H; Ohya, S | 1 |
| Cid, A; Jarque, I; Martín, G; Pérez-Bellés, C; Salavert, M; Sanz, MA | 1 |
| Blandino, G; Caccamo, F; Milazzo, I; Musumeci, R; Nicoletti, G; Speciale, A | 1 |
| Benquan, W; Jiaxing, Z; Kouxing, Z; Shuqing, T; Tiantuo, Z; Yingchun, T | 1 |
| Hirai, K; Honda, T; Yamazaki, Y | 1 |
| Duarte Reis, M; Freitas, IP; Guerra Rodrigo, F; Sousa Coutinho, V | 1 |
| Bocchi, L; Ceffa, R; Cerretani, D; Fornara, P; Ghisellini, F; Giorgi, G; Neri, L; Ritter, MA | 1 |
| Hiramatsu, K; Kuroda, H; Kuroda, M; Mori, H; Oshima, T; Takeuchi, F | 1 |
| Afif, C; Boktour, MR; Escalante, C; Hachem, RY; Hanna, HA; Husni, R; Jacobson, K; Kantarjian, H; Kontoyiannis, D; Levett, LM; Raad, II; Rolston, KV; Whimbey, EE | 1 |
| Buchheidt, D; Hofheinz, R; Hummel, M | 1 |
| Benjamin, WH; Chavers, LS; Chavers, P; Funkhouser, E; Moser, SA; Stamm, AM; Waites, KB | 1 |
| Xiang, XD; Yang, H; Yi, ZM | 1 |
| Chong, Y; Hong, SG; Jang, SJ; Kim, M; Lee, HJ; Lee, K; Ryoo, N | 1 |
| Engelbert, M; Grasbon, T; Kampik, A; Klauss, V; Miño de Kaspar, H; Schulze-Schwering, M; Ta, CN; Thiel, M | 1 |
| Dou, Y; Liao, ZJ; Zhang, Q | 1 |
| Shiotani, J; Takehana, K | 1 |
| Greenberg, GR | 1 |
| Chudnicka, A; Kozioł-Montewka, M | 1 |
| Ahmed, U; Burney, IA; Khan, MA; Shamim, A; Siddiqui, BK; Yosuf, MA; Zakiullah, N | 1 |
| Balaban, N; Cirioni, O; D'Amato, G; Del Prete, MS; Dell'Acqua, G; Ghiselli, R; Giacometti, A; Mocchegiani, F; Orlando, F; Rocchi, M; Saba, V; Scalise, G; Silvestri, C | 1 |
| Li, DJ; Liu, WL; Sun, ZY; Zhu, XH | 1 |
| Balaban, N; Cirioni, O; Dell'Acqua, G; Ghiselli, R; Giacometti, A; Licci, A; Mocchegiani, F; Orlando, F; Saba, V; Scalise, G; Silvestri, C | 1 |
| Chong, Y; Ha, GY; Jeong, SH; Lee, K; Lim, HS; Park, KH; Shin, JH; Yong, D | 1 |
| Argaud, L; Le Scanff, J; Martin, O; Mohammedi, I; Robert, D; Thiebaut, A | 1 |
| Arakawa, S; Deguchi, T; Egashira, T; Fujime, M; Fujita, K; Fukuhara, Y; Furuya, N; Hirakata, Y; Hirose, T; Igari, J; Imafuku, Y; Ishibashi, K; Ishihara, S; Kamidono, S; Kitamura, M; Kobayashi, Y; Kohno, S; Kondo, A; Konishi, T; Kumamoto, Y; Kumon, H; Kunishima, Y; Matsuda, J; Matsuda, S; Matsukawa, M; Matsumoto, T; Monden, K; Murai, M; Muratani, T; Naito, S; Nakano, M; Oguri, T; Oka, T; Ooe, H; Sato, S; Shigeta, S; Suzutani, T; Tsukamoto, T; Uchida, H; Watanabe, K; Yamaguchi, K; Yamaguti, O; Yoshida, H | 1 |
| Leaños-Miranda, BE; Miranda-Novales, G; Solórzano-Santos, F; Vilchis-Pérez, M | 1 |
| Cakir, B; Cobanoglu, S; Hamamcioglu, MK; Hicdonmez, T; Kilincer, C | 1 |
| Lartigue, MF; Nordmann, P; Poirel, L; Poyart, C; Réglier-Poupet, H | 1 |
| Bradford, PA; Jones, CH; Petersen, PJ | 1 |
| Bochnia, M; Fraczek, M; Jankowska-Konsur, A; Jaworska, M; Kubacka, M; Mazur, M; Preś, K; Rostkowska-Nadolska, B; Steinmetz-Beck, A | 1 |
| Cengiz, CK | 1 |
| Hoda, MQ; Hussein, K; Manasia, R; Salahuddin, N; Samad, A; Siddiqui, S; Zafar, A | 1 |
| Bertoluci, DF; Dell'Aquilla, AM; López, KJ; Santos, SR; Vicente, KM | 1 |
| Delgado, J; Diaz, LA; Galvis, V; Gómez, AJ; Tello, A; Valencia, F | 1 |
| De Kaspar, HM; Engelbert, M; Kampik, A; Mette, M; Ta, CN; Thiel, M | 1 |
| Flores, M; Murillo, J; Stumpf, PG | 1 |
| Akinci, E; Balaban, N; Baran, G; Bodur, H; Cevik, MA; Erbay, A; Onguru, P | 1 |
| Ascerić, M; Custović, A; Hadzić, S; Zulcić-Nakić, V | 1 |
| Batlle, M; de la Cámara, R; de la Rubia, J; Debén, G; Díaz, J; García, R; Jarque, I; Juliá, A; Lahuerta, JJ; López, J; Martino, R; Montesinos, P; Rovira, M; Sanz, MA; Vázquez, L | 1 |
| Asner, S; Buclin, T; Calandra, T; Erard, V; Lamoth, F; Marchetti, O | 1 |
| Greenberg, RE; Kurtz, LE | 1 |
| Ariza, J; Cabellos, C; Domínguez, MA; Fernández, R; Gudiol, F; Pachón-Ibáñez, ME; Ribes, S; Tubau, F | 2 |
| Gonzalez, F; Li, X; Mu, D; Tang, J; Wang, H; Xiong, Y | 1 |
| Asano, Y; Hashido, H; Kawamoto, H; Matsubara, S; Matsukawa, Y; Mikamo, H; Mitsuyama, J; Miyabe, T; Nomura, N; Sawamura, H; Suematsu, H; Teraji, M; Watanabe, K; Yamaoka, K | 1 |
| Araj, GF; Awar, GN; Baban, TA; Kanj, SS; Naba, MR; Tabbarah, ZA | 1 |
| Chong, Y; Kim, JJ; Kim, S; Koh, E; Lee, CH; Lee, J; Lee, K; Lee, MA; Roh, KH; Yong, D | 1 |
| Higashi, M; Iwasaka, T; Kakimoto, S; Kido, E; Morimoto, S; Morita, T; Someya, K; Sumitani, N; Suzuki, K; Takagishi, H; Yasui, A | 1 |
| Asghar, MN; Brooks, JD; Butcher, EC; Habtezion, A; Kronmal, GS; Omary, MB; Toivola, DM | 1 |
| Araújo, MT; Nunes, AP; Santos, KR; Silva, LV | 1 |
| García García, C; Gómez Ruiz, CJ; Jimeno Ayllón, C; Martínez Fernández, R; Morillas Ariño, J; Pérez Gil, MA; Pérez Sola, A; Relanzón Molinero, S; Reyes Guevara, AK; Serrano Sánchez, L | 1 |
| Amoros, F; Borrás-Blasco, J; Enriquez, R; Navarro-Ruiz, A; Padilla, S; Sirvent, AE; Solavera, J | 1 |
| Altunsoy, A; Aypak, C; Azap, A; Balık, I; Ergönül, Ö | 1 |
| Brothier, E; Cournoyer, B; Deredjian, A; Favre-Bonté, S; Nazaret, S; Pinot, C; Segonds, C | 1 |
| Aminaka, M; Cui, L; Hiramatsu, K; Hori, S; Ito, T; Jin, J; Kaneko, K; Katayama, Y; Kobayashi, H; Kondo, S; Kurosawa, H; Nakamura, A; Oguri, T; Okuzumi, K; Yamakawa, J | 1 |
| Aleksandrova, IV; Borisova, LA; Chernen'kaia, TV; Kosolapov, DA; Vorob'eva, TIu | 1 |
| Choi, SH; Chung, J; Hong, SB; Jang, HJ; Kim, JW; Koh, Y; Lim, CM | 1 |
| Holodniy, M; Lucero, CA; Mercier, RC; Nguyen, N; Oda, G; Ryono, RA; Schirmer, PL | 1 |
| Božić, M; Jovanović, M; Knežević, M; Rašić, D; Stojković, M | 1 |
| Bogomolova, NS; Bol'shakov, LV; Kuznetsova, SM; Parshin, VD; Vishnevskaia, GA | 1 |
| Choi, M; Karp, NS; Levine, SM; Weichman, KE; Wilson, SC | 1 |
| Haque, N; Hoque, SM; Hossain, MA; Kabir, MR; Paul, SK; Rahman, A; Sultana, S | 1 |
| Calcaño, C; Fuenmayor, Z; Montaño, C; Piñerúa Gonsálvez, JF; Rodney, H; Rodney, M; Zambrano Infantinot, Rdel C | 1 |
| Bolac, C; Brassat, S; Camus, M; Cante, V; Guillet, G; Paquier-Valette, C | 1 |
| Sullivan, T | 1 |
| Bes, M; Clair, P; Dauwalder, O; Dumitrescu, O; Freydière, AM; Laurent, F; Martra, A; Reix, P; Renzoni, A; Reverdy, ME; Roch, M; Vandenesch, F | 1 |
| de Haller, R; Mavrakanas, TA; Philippe, J | 1 |
| Barthélémy, C; Chai, F; Debaene, B; Décaudin, B; Drouet, M; Lebuffe, G; Odou, P | 1 |
| Amemoto, Y; Aoyama, T; Arakawa, S; Deguchi, T; Egawa, S; Fujimoto, Y; Fujisawa, M; Goto, H; Hamasuna, R; Hanaki, H; Hashimura, T; Hayami, H; Hirose, T; Ichikawa, T; Inatomi, H; Ishihara, S; Ishikawa, K; Ishitoya, S; Ito, N; Ito, T; Iwata, S; Kadota, J; Kagara, I; Kaku, M; Kanamaru, S; Kato, M; Kawanishi, H; Kimura, T; Kiyota, H; Kobayashi, K; Kobuke, M; Koda, S; Komeda, H; Kumon, H; Kunishima, Y; Maeda, H; Matsubara, A; Matsuda, Y; Matsui, T; Matsukawa, M; Matsumoto, M; Matsumoto, T; Minamitani, S; Mita, K; Mitsumori, K; Muranaka, T; Nakamura, I; Nishimura, K; Oka, H; Okumura, K; Onishi, H; Onodera, S; Sato, J; Shigeta, M; Sunakawa, K; Taguchi, K; Takahashi, K; Takahashi, S; Takahashi, Y; Takenaka, T; Tanaka, K; Togo, Y; Tsugawa, M; Tsukamoto, T; Uehara, S; Wakeda, H; Watanabe, A; Yamada, D; Yamamoto, S; Yamashita, M; Yasuda, M | 1 |
| Altboum, Z; Bar-David, E; Glinert, I; Kobiler, D; Levy, H; Schlomovitz, J; Sittner, A; Weiss, S | 1 |
| Almela, M; Armero, Y; Cervera, C; del Río, A; Entenza, JM; Falces, C; García-de-la-Mària, C; Gasch, O; Gatell, JM; Marco, F; Mestres, CA; Miró, JM; Moreillon, P; Moreno, A; Ninot, S; Pericás, JM; Soy, D | 1 |
| Al-Dahir, S; Brakta, F; Gillard, CJ | 1 |
| Caro-Vega, JM; García-Quintanilla, M; McConnell, MJ; Moreno-Martínez, P; Pachón, J; Pulido, MR | 1 |
| Compain, F; Guerot, E; Jarraud, S; Podglajen, I; Richaud, C; Rossi, B; Rostane, H | 1 |
| Afeltra, J; Bravo, M; Casadei, DH; Dotta, AC; Linares, L; Pujato, N; Radisic, MV; Vitale, RG | 1 |
| Chang, Y; Hsieh, PH; Hsu, YH; Hu, CC; Shih, HN; Ueng, SW | 1 |
| Gemperli, R; Gomez, DS; Levin, AS; Machado, AS; Oliveira, MS; Sanches, C; Santos, SRCJ; Silva Junior, CVD | 1 |
| Abdelhady, W; Bayer, AS; Estellés, A; Gonzales, R; Kauvar, LM; Leighton, A; Li, L; Ryser, S; Tenorio, E; Xiong, YQ | 1 |
| Bo, H; Hui-Min, Y; Lin Liu, Y; Shamsi, BH; Xu-Chun, M; Yan-Ping, W | 1 |
| Branski, LK; Cambiaso-Daniel, J; Capek, KD; De Crescenzo, A; Finnerty, CC; Herndon, DN; Hundeshagen, G; Killion, EA; Kinsky, MP; Mlcak, RP; Norbury, WB; Sljivich, M; Voigt, CD | 1 |
| Almela, M; Cruceta, A; de Alarcón, A; Del Río, A; Eworo, A; García-de-la-Mària, C; Marco, F; Mestres, CA; Miró, JM; Moreno, A; Muñoz, P; Paré, JC; Peña, C; Pericàs, JM | 1 |
| Campos, M; Canovas-Segura, B; Juarez, JM; Marin, R; Morales, A; Palacios, F | 1 |
| Chen, PX; Fu, JL; Gu, XX; Jiang, HX; Yang, L; Zhang, LJ | 1 |
| Gong, N; Jiang, J; Yang, L; Zhou, H | 1 |
| Chang, TY; Chen, HY; Cheng, YH; Chou, YC; Sun, JR | 1 |
| Ghaemi, EA; Khori, V; Mohammadi-Berenjestanaki, H; Shirzad-Aski, H | 1 |
| Al Qarni, A; Arapis, K; Augustin, P; Grall, N; Montravers, P; Parenti Ribeiro, L; Tanaka, S; Tran-Dinh, A | 1 |
| Cao, L; Ji, B; Li, G; Mu, W; Wang, Y; Zhang, X | 1 |
| Conterno, LO; Dayer, M; Gonzalez Garay, AG; Martí-Amarista, CE; Martí-Carvajal, AJ | 1 |
| Abdul Wahab, Z; Amin Nordin, S; Ibrahim, R; Ishak, N | 1 |
| Bastiaanssen, TFS; Cryan, JF; Dinan, TG; Fitzgerald, P; Fulling, C; Moloney, GM; O'Connor, R; O'Riordan, KJ; Schellekens, H | 1 |
| Booncharoen, S; Chaiyapoke, C; Chanawong, A; Lulitanond, A; Srisrattakarn, A; Tavichakorntrakool, R; Tippayawat, P; Wongthong, S | 1 |
| Alishahi, M; Arastehfar, A; Davani, F; Khorram, M; Sabzi, M; Zomorodian, K | 1 |
| Hou, JY; Huang, HM; Huang, TH; Liu, HC; Lu, CH; Sun, FJ; Yeh, TC | 1 |
| Chung, KK; DeLuca, JP; Kress, AT; Reed, T; Selig, DJ; Stewart, IJ | 1 |
| Ahmad, S; Ahmed, S; Ali, F; Farooq, M; Haq, I; Qureshi, SA; Rasheed, A; Sabir, MS; Shakeela, Q; Uzma, B | 1 |
| Corrales, MI; Galvis, V; Garcia, D; Parra, MM; Rangel, CM; Sánchez-Ávila, R; Tello, A; Varón, CL; Villareal, E; Villarreal, D | 1 |
| Amoureux, L; Casenaz, A; Guilloteau, A; Labattut, L; Magallon, A; Neuwirth, C; Piroth, L; Sixt, T | 1 |
| Agarwal, M; Gandhi, A; Mayor, R; Paul, L; Ranjan, R; Singh, S | 1 |
| Liu, G; Qi, Y | 1 |
| Jindai, K; Kitaura, S; Okamoto, K | 1 |
| Jia, L; Jiang, Y; Li, X; Peng, Z; Wang, Y | 1 |
| Álvarez-Pérez, S; Anega, B; Blanco, JL; García, ME; Hernández, M | 1 |
8 review(s) available for vancomycin and imipenem, anhydrous
| Article | Year |
|---|---|
New directions in antibacterial research.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacteria; Drug Resistance, Microbial; Molecular Sequence Data; Molecular Structure | 1996 |
Cephalosporins, vancomycin, aminoglycosides and other drugs, especially in combination, for the treatment of methicillin-resistant staphylococcal infections.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Drug Therapy, Combination; Glycopeptides; Imipenem; Methicillin; Norfloxacin; Oxacillin; Pefloxacin; Penicillin Resistance; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Teicoplanin; Thienamycins; Vancomycin | 1986 |
Clinical pharmacokinetics during continuous haemofiltration.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Half-Life; Hemofiltration; Humans; Imipenem; Metabolic Clearance Rate; Pharmacokinetics; Protein Binding; Tissue Distribution; Ultrafiltration; Vancomycin | 1994 |
Infectious complications in the immunocompromised host. The antimicrobial armamentarium.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Aminoglycosides; Amphotericin B; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Antiprotozoal Agents; Azoles; Aztreonam; Cephalosporins; Fluoroquinolones; Foscarnet; Ganciclovir; Humans; Imipenem; Immunocompromised Host; Infections; Neoplasms; Pneumonia, Pneumocystis; Vancomycin | 1993 |
Antibiotics should be used as first-line therapy for Crohn's disease.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Crohn Disease; Humans; Imipenem; Metronidazole; Time Factors; Treatment Outcome; Vancomycin | 2004 |
Acute post-surgical bilateral orbital gas-producing infection - a case report and literature review.
Topics: Acute Disease; Anti-Bacterial Agents; Drug Therapy, Combination; Emphysema; Eye Infections, Bacterial; Eyelid Diseases; Glucocorticoids; Humans; Imipenem; Male; Methylprednisolone; Metronidazole; Middle Aged; Orbital Diseases; Postoperative Complications; Staphylococcal Infections; Tomography, X-Ray Computed; Vancomycin | 2012 |
Acute pulmonary involvement by paracoccidiodomycosis disease immediately after kidney transplantation: Case report and literature review.
Topics: Amphotericin B; Antifungal Agents; Bronchoalveolar Lavage; Bronchoalveolar Lavage Fluid; Bronchoscopy; Female; Graft Rejection; Humans; Imipenem; Immunity, Humoral; Immunosuppression Therapy; Immunosuppressive Agents; Itraconazole; Kidney Failure, Chronic; Kidney Transplantation; Latin America; Lung Diseases, Fungal; Methylprednisolone; Middle Aged; Paracoccidioides; Paracoccidioidomycosis; Plasmapheresis; Respiration, Artificial; Tomography, X-Ray Computed; Vancomycin | 2017 |
A comparison of different antibiotic regimens for the treatment of infective endocarditis.
Topics: Anti-Bacterial Agents; Endocarditis, Bacterial; Female; Fosfomycin; Humans; Imipenem; Levofloxacin; Male; Penicillins; Randomized Controlled Trials as Topic; Vancomycin | 2020 |
16 trial(s) available for vancomycin and imipenem, anhydrous
| Article | Year |
|---|---|
Imipenem versus netilmicin and vancomycin in the treatment of CAPD peritonitis.
Topics: Female; Humans; Imipenem; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Prospective Studies; Recurrence; Vancomycin | 1992 |
[Incidence, frequency and resistance characteristics of methicillin-oxacillin resistant Staphylococcus aureus strains in Germany].
Topics: Ciprofloxacin; Clindamycin; Drug Resistance, Microbial; Fosfomycin; Germany; Humans; Imipenem; Methicillin; Microbial Sensitivity Tests; Oxacillin; Penicillin Resistance; Staphylococcus aureus; Teicoplanin; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 1992 |
[Evaluation of three types of empirical antibiotherapy in patients with febrile neutropenia: imipenem-cilastatin versus ceftazidime-vancomycin versus ticarcillin-amikacin-vancomycin].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Bacterial Infections; Ceftazidime; Cilastatin; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Middle Aged; Neutropenia; Prospective Studies; Ticarcillin; Vancomycin | 1992 |
Imipenem compared with ceftazidime plus vancomycin as initial therapy for fever in neutropenic children with cancer.
Topics: Adolescent; Bacterial Infections; Ceftazidime; Child; Child, Preschool; Drug Evaluation; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Infant; Male; Neoplasms; Neutropenia; Vancomycin | 1991 |
A prospective, randomized study of the comparative safety and efficacy of intraperitoneal imipenem versus vancomycin and netilmicin in the treatment of peritonitis on CAPD.
Topics: Drug Therapy, Combination; Female; Humans; Imipenem; Male; Middle Aged; Netilmicin; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Prospective Studies; Vancomycin | 1995 |
Monotherapy for fever and neutropenia in cancer patients: a randomized comparison of ceftazidime versus imipenem.
Topics: Acyclovir; Adolescent; Adult; Aged; Bacterial Infections; Cause of Death; Ceftazidime; Child; Child, Preschool; Female; Fever; Fever of Unknown Origin; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Prospective Studies; Vancomycin | 1995 |
Comparison of imipenem versus cefuroxime plus tobramycin as empirical therapy for febrile granulocytopenic patients and efficacy of vancomycin and aztreonam in case of failure.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Aztreonam; Cefuroxime; Drug Therapy, Combination; Female; Fever of Unknown Origin; Gram-Positive Bacterial Infections; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Tobramycin; Treatment Failure; Vancomycin | 1994 |
A comparison of aztreonam plus vancomycin and imipenem plus vancomycin as initial therapy for febrile neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Leukocyte Count; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Neoplasms; Neutropenia; Neutrophils; Prospective Studies; Vancomycin | 1996 |
Imipenem or cefoperazone-sulbactam combined with vancomycin for therapy of presumed or proven infection in neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cefoperazone; Drug Therapy, Combination; Humans; Imipenem; Middle Aged; Neoplasms; Neutropenia; Prospective Studies; Sulbactam; Vancomycin | 1996 |
[Imipenem combined with teicoplanin or vancomycin in the initial empirical treatment of febrile neutropenia. Analysis of the primary response and of a global sequential strategy in 126 episodes].
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Infections; Male; Middle Aged; Neutropenia; Prospective Studies; Teicoplanin; Thienamycins; Vancomycin | 1996 |
[Effect of imipenem/cilastatin combined with vancomycin for MRSA infection].
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Synergism; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Methicillin Resistance; Middle Aged; Pneumonia, Staphylococcal; Staphylococcal Infections; Urinary Tract Infections; Vancomycin | 1997 |
Treatment of pneumonia in mechanically ventilated trauma patients. Results of a prospective trial.
Topics: Aztreonam; Bronchoalveolar Lavage Fluid; Cilastatin; Cross Infection; Drug Therapy, Combination; HLA-DR Antigens; Humans; Imipenem; Pneumonia; Prospective Studies; Respiration, Artificial; Vancomycin; Wounds and Injuries | 1997 |
Triple combination antimicrobial regimen in the treatment of infections of neutropenic cancer patients.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antineoplastic Agents; Drug Therapy, Combination; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Mycoplasma Infections; Neoplasms; Neutropenia; Pefloxacin; Thienamycins; Vancomycin | 1997 |
Treatment of febrile neutropenic patients with cancer who require hospitalization: a prospective randomized study comparing imipenem and cefepime.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Catheterization, Central Venous; Cefepime; Cephalosporins; Female; Fever; Hospitalization; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Practice Guidelines as Topic; Prospective Studies; Risk Factors; Vancomycin | 2003 |
Early use of imipenem/cilastatin and vancomycin followed by de-escalation versus conventional antimicrobials without de-escalation for patients with hospital-acquired pneumonia in a medical ICU: a randomized clinical trial.
Topics: Aged; Anti-Infective Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Cross Infection; Drug Combinations; Female; Hospital Mortality; Humans; Imipenem; Intensive Care Units; Male; Middle Aged; Pneumonia, Bacterial; Time Factors; Treatment Outcome; Vancomycin | 2012 |
Efficacy and safety of fosfomycin plus imipenem versus vancomycin for complicated bacteraemia and endocarditis due to methicillin-resistant Staphylococcus aureus: a randomized clinical trial.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Endocarditis; Female; Fosfomycin; Humans; Imipenem; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Treatment Outcome; Vancomycin | 2018 |
215 other study(ies) available for vancomycin and imipenem, anhydrous
| Article | Year |
|---|---|
Synthesis and activity of 2-(sulfonamido)methyl-carbapenems: discovery of a novel, anti-MRSA 1,8-naphthosultam pharmacophore.
Topics: Bacterial Proteins; Carbapenems; Carrier Proteins; Drug Resistance, Microbial; Gram-Positive Bacteria; Hexosyltransferases; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases | 1999 |
Synthesis and properties of 2-(naphthosultamyl)methyl-carbapenems with potent anti-MRSA activity: discovery of L-786,392.
Topics: Animals; Carbapenems; Drug Resistance, Microbial; Gram-Positive Bacteria; Humans; Lactams; Mice; Microbial Sensitivity Tests; Structure-Activity Relationship; Thiazoles | 1999 |
2-Naphthylcarbapenems: broad spectrum antibiotics with enhanced potency against MRSA.
Topics: Anti-Bacterial Agents; Carbapenems; Dipeptidases; Methicillin Resistance; Molecular Structure; Naphthalenes; Staphylococcus | 1999 |
The synthesis and anti-MRSA activity of amidinium-substituted 2-dibenzofuranylcarbapenems.
Topics: Amidines; Carbapenems; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus | 1999 |
Dicationic 2-fluorenonylcarbapenems: potent anti-MRS agents with improved solubility and pharmacokinetic properties.
Topics: Animals; Carbapenems; Cations; Half-Life; Macaca mulatta; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Solubility; Staphylococcal Infections; Staphylococcus aureus | 1999 |
New anti-MRSA cephalosporins with a basic aminopyridine at the C-7 position.
Topics: Aminopyridines; Cephalosporins; Combinatorial Chemistry Techniques; Methicillin Resistance; Microbial Sensitivity Tests; Solubility; Staphylococcus aureus; Structure-Activity Relationship | 2001 |
New antibacterial agents derived from the DNA gyrase inhibitor cyclothialidine.
Topics: Animals; Anti-Bacterial Agents; DNA Gyrase; Drug Resistance, Multiple, Bacterial; Gram-Positive Bacteria; HeLa Cells; Humans; Lactams; Lactones; Mice; Microbial Sensitivity Tests; Models, Molecular; Oxadiazoles; Peptides, Cyclic; Protein Subunits; Staphylococcal Infections; Stereoisomerism; Structure-Activity Relationship; Topoisomerase II Inhibitors; Toxicity Tests | 2004 |
In vitro activities of the lipopeptides palmitoyl (Pal)-Lys-Lys-NH(2) and Pal-Lys-Lys alone and in combination with antimicrobial agents against multiresistant gram-positive cocci.
Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Drug Synergism; Gram-Positive Cocci; Hemolysis; Humans; Lipoproteins; Microbial Sensitivity Tests; Molecular Structure; Peptides | 2007 |
In vitro activity of aurein 1.2 alone and in combination with antibiotics against gram-positive nosocomial cocci.
Topics: Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Cross Infection; Drug Synergism; Drug Therapy, Combination; Gram-Positive Cocci; Microbial Sensitivity Tests | 2007 |
In vitro and in vivo antibacterial activities of heteroaryl isothiazolones against resistant gram-positive pathogens.
Topics: Animals; Anti-Infective Agents; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Mice; Microbial Sensitivity Tests; Quinolones; Thiazoles | 2007 |
Polyamine effects on antibiotic susceptibility in bacteria.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Drug Resistance, Bacterial; Drug Synergism; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Polyamines; Spermine; Staphylococcus aureus | 2007 |
CP5484, a novel quaternary carbapenem with potent anti-MRSA activity and reduced toxicity.
Topics: Anti-Bacterial Agents; Carbapenems; Imidazoles; Kinetics; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus; Stereoisomerism; Structure-Activity Relationship; Thiazoles | 2007 |
Antimicrobial activities of Ceftaroline and ME1036 tested against clinical strains of community-acquired methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Ceftaroline; Cephalosporins; Community-Acquired Infections; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; United States | 2008 |
Methicillin-resistant Staphylococcus saprophyticus isolates carrying staphylococcal cassette chromosome mec have emerged in urogenital tract infections.
Topics: Bacterial Proteins; Chromosomes, Bacterial; Electrophoresis, Gel, Pulsed-Field; Methicillin Resistance; Molecular Sequence Data; Polymerase Chain Reaction; Sequence Analysis, DNA; Staphylococcal Infections; Staphylococcus; Urinary Tract Infections | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; United States | 2008 |
Serial daptomycin selection generates daptomycin-nonsusceptible Staphylococcus aureus strains with a heterogeneous vancomycin-intermediate phenotype.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Daptomycin; Drug Resistance, Bacterial; Humans; Membrane Fluidity; Membrane Potentials; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oligonucleotide Array Sequence Analysis; Phenotype; Vancomycin | 2008 |
In vitro activities of doripenem, a new broad-spectrum carbapenem, against recently collected clinical anaerobic isolates, with emphasis on the Bacteroides fragilis group.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroides fragilis; Carbapenems; Doripenem; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests | 2008 |
Establishment of in vitro susceptibility testing methodologies and comparative activities of piperacillin in combination with the penem {beta}-lactamase inhibitor BLI-489.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; Drug Combinations; Enzyme Inhibitors; Humans; Lactams; Microbial Sensitivity Tests; Piperacillin | 2009 |
Synthesis of novel di- and tricationic carbapenems with potent anti-MRSA activity.
Topics: Anti-Bacterial Agents; Carbapenems; Cations; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Solubility | 2009 |
Contribution of vraSR and graSR point mutations to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Chromosome Walking; DNA-Binding Proteins; Genetic Engineering; Genome, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Point Mutation; Sequence Analysis, DNA; Sequence Homology, Amino Acid; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2009 |
Selection of heterogeneous vancomycin-intermediate Staphylococcus aureus by imipenem.
Topics: Anti-Bacterial Agents; beta-Lactams; Blotting, Northern; Drug Resistance, Multiple, Bacterial; Genome, Bacterial; Imipenem; Microbial Sensitivity Tests; Mutation; Sequence Analysis, DNA; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2009 |
Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria.
Topics: Anti-Bacterial Agents; Azepines; Bacteria, Anaerobic; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests | 2009 |
In vitro activity of TR-700, the active ingredient of the antibacterial prodrug TR-701, a novel oxazolidinone antibacterial agent.
Topics: Anti-Bacterial Agents; Bacteria; Enterococcus; Haemophilus influenzae; Microbial Sensitivity Tests; Moraxella catarrhalis; Oxazolidinones; Staphylococcus; Streptococcus | 2009 |
Protein kinase G is required for intrinsic antibiotic resistance in mycobacteria.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Blotting, Western; Cyclic GMP-Dependent Protein Kinases; Drug Resistance, Microbial; Mycobacterium; Mycobacterium tuberculosis; Phagosomes; Reverse Transcriptase Polymerase Chain Reaction | 2009 |
The chemical synthesis and antibiotic activity of a diverse library of 2-aminobenzimidazole small molecules against MRSA and multidrug-resistant A. baumannii.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Benzimidazoles; Drug Resistance, Multiple, Bacterial; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Conformation; Small Molecule Libraries; Stereoisomerism; Structure-Activity Relationship | 2010 |
Comparative in vitro activities of nemonoxacin (TG-873870), a novel nonfluorinated quinolone, and other quinolones against clinical isolates.
Topics: Anti-Bacterial Agents; Aza Compounds; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Cocci; Humans; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Quinolones; Taiwan | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Activity of ceftaroline against recent emerging serotypes of Streptococcus pneumoniae in the United States.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Communicable Diseases, Emerging; Drug Resistance, Multiple, Bacterial; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Pneumococcal Infections; Serotyping; Streptococcus pneumoniae; United States | 2010 |
Antimicrobial susceptibility patterns for recent clinical isolates of anaerobic bacteria in South Korea.
Topics: Anti-Infective Agents; Aza Compounds; Bacteria, Anaerobic; Bacteroides fragilis; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Positive Cocci; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Republic of Korea | 2010 |
Comparative in vitro activity profiles of novel bis-indole antibacterials against gram-positive and gram-negative clinical isolates.
Topics: Anti-Bacterial Agents; Gram-Negative Aerobic Bacteria; Gram-Positive Bacteria; Indoles; Microbial Sensitivity Tests | 2010 |
A new DNA gyrase inhibitor subclass of the cyclothialidine family based on a bicyclic dilactam-lactone scaffold. Synthesis and antibacterial properties.
Topics: Animals; Anti-Bacterial Agents; Bacteria; DNA Gyrase; Enzyme Inhibitors; Lactams; Lactones; Mice; Microbial Sensitivity Tests; Models, Molecular; Peptides, Cyclic; Protein Conformation; Topoisomerase II Inhibitors | 2011 |
Discovery of nosokophic acid, a predicted intermediate of moenomycins, from nosokomycin-producing Streptomyces sp. K04-0144.
Topics: Anti-Bacterial Agents; Bambermycins; Drug Discovery; Drug Synergism; Hexuronic Acids; Imipenem; Magnetic Resonance Spectroscopy; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Organophosphates; Streptomyces | 2013 |
Cybastacines A and B: Antibiotic Sesterterpenes from a Nostoc sp. Cyanobacterium.
Topics: Anti-Bacterial Agents; Guanidine; Nostoc; Sesterterpenes; Spain | 2018 |
Novel Broad-Spectrum Antimicrobial Peptide Derived from Anoplin and Its Activity on Bacterial Pneumonia in Mice.
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Antineoplastic Agents; Cell Line; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Structure; Pneumonia, Bacterial; Pore Forming Cytotoxic Proteins; Structure-Activity Relationship; Wasp Venoms | 2021 |
Metallo-β-lactamases inhibitor fisetin attenuates meropenem resistance in NDM-1-producing Escherichia coli.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Escherichia coli; Flavonols; Meropenem; Microbial Sensitivity Tests | 2022 |
Pharmacodynamic effects of antibiotics. Studies on bacterial morphology, initial killing, postantibiotic effect and effective regrowth time.
Topics: Amdinocillin; Amikacin; Animals; Anti-Bacterial Agents; Aztreonam; Cephalosporins; Daptomycin; Drug Synergism; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Peptides; Piperacillin; Vancomycin | 1992 |
[Chemotherapy of MRSA infections].
Topics: Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Drug Combinations; Drug Therapy, Combination; Fosfomycin; Humans; Imipenem; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Sulfamethoxazole; Trimethoprim; Vancomycin | 1992 |
[Bacteriostatic activity and killing curves of eight antibiotics against seven strains of penicillin G-resistant pneumococci].
Topics: Amoxicillin; Cefotaxime; Drug Synergism; Drug Therapy, Combination; Erythromycin; Fosfomycin; Humans; Imipenem; In Vitro Techniques; Penicillin G; Penicillin Resistance; Rifampin; Streptococcus pneumoniae; Vancomycin | 1992 |
[Methicillin resistant Staphylococcus aureus].
Topics: Anti-Bacterial Agents; Cross Infection; Humans; Imipenem; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1992 |
Imipenem/vancomycin for Rhodococcus equi pulmonary infection in HIV-positive patient.
Topics: Actinomycetales Infections; Adult; Drug Therapy, Combination; HIV Seropositivity; Humans; Imipenem; Lung Diseases; Male; Occupational Diseases; Rhodococcus; Vancomycin | 1991 |
[A lethal course in pseudomembranous enterocolitis during the parenteral administration of vancomycin and imipenem].
Topics: Colon; Combined Modality Therapy; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Humans; Imipenem; Infusions, Intravenous; Middle Aged; Postoperative Complications; Vancomycin | 1992 |
Endocarditis caused by Corynebacterium group D2.
Topics: 4-Quinolones; Adult; Anti-Infective Agents; Corynebacterium Infections; Endocarditis; Humans; Imipenem; Male; Species Specificity; Vancomycin | 1991 |
Vancomycin-resistant Corynebacterium species causing prosthetic valve endocarditis successfully treated with imipenem and ciprofloxacin.
Topics: Adult; Ciprofloxacin; Corynebacterium; Corynebacterium Infections; Drug Resistance, Microbial; Endocarditis, Bacterial; Female; Heart Valve Prosthesis; Humans; Imipenem; Mitral Valve; Species Specificity; Vancomycin | 1991 |
[Drug therapy of intractable methicillin-resistant staphylococcal infections].
Topics: Cefotiam; Cross Infection; Drug Therapy, Combination; Glycopeptides; Humans; Imipenem; Methicillin Resistance; Minocycline; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin | 1990 |
In vitro antimicrobial activity of imipenem in combination with vancomycin or teicoplanin against Staphylococcus aureus and Staphylococcus epidermidis.
Topics: Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Glycopeptides; Humans; Imipenem; Microbial Sensitivity Tests; Staphylococcus aureus; Staphylococcus epidermidis; Teicoplanin; Vancomycin | 1990 |
Selection for vancomycin resistance in clinical isolates of Staphylococcus haemolyticus.
Topics: Bacterial Proteins; Coagulase; Drug Resistance, Microbial; Electrophoresis, Polyacrylamide Gel; Humans; Imipenem; Microbial Sensitivity Tests; Species Specificity; Staphylococcus; Time Factors; Vancomycin | 1990 |
Further studies on post-antibiotic effect and synergism in two strains of Streptococcus faecalis.
Topics: Ampicillin; Drug Synergism; Enterococcus faecalis; Gentamicins; Imipenem; Microbial Sensitivity Tests; Netilmicin; Piperacillin; Streptomycin; Time Factors; Tobramycin; Vancomycin | 1989 |
[Dosage adjustment of drugs during continuous hemofiltration. Results and practical consequences of a prospective clinical study].
Topics: Adult; Aged; Cefotaxime; Ceftazidime; Digitoxin; Digoxin; Hemofiltration; Humans; Imipenem; Kidney Failure, Chronic; Metronidazole; Middle Aged; Netilmicin; Pharmaceutical Preparations; Phenobarbital; Phenytoin; Theophylline; Tobramycin; Vancomycin | 1989 |
Comparative study of clindamycin, imipenem, oxacillin and vancomycin in the infected granuloma pouch model.
Topics: Animals; Anti-Bacterial Agents; Bacteroides fragilis; Bacteroides Infections; Clindamycin; Granuloma; Imipenem; Male; Microbial Sensitivity Tests; Oxacillin; Rats; Rats, Inbred Strains; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1989 |
Clostridium perfringens type A. Comparison of in vitro and in vivo activity of twelve antimicrobial drugs.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Clostridium perfringens; Fosfomycin; Gas Gangrene; Imipenem; Metronidazole; Mice; Microbial Sensitivity Tests; Oxacillin; Penicillin G; Thienamycins; Vancomycin | 1986 |
Streptococcus faecalis: in vitro susceptibility to antimicrobial drugs, single and combined, with and without defibrinated human blood.
Topics: Animals; Anti-Bacterial Agents; Blood; Cattle; Enterococcus faecalis; Fibrin; Fusidic Acid; Gentamicins; Humans; Imipenem; Microbial Sensitivity Tests; Ofloxacin; Oxazines; Penicillins; Rabbits; Thienamycins; Vancomycin | 1986 |
Identification of Streptococcus faecalis and Streptococcus faecium and susceptibility studies with newly developed antimicrobial agents.
Topics: Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Enterococcus faecalis; Erythromycin; Fluoroquinolones; Humans; Imipenem; Microbial Sensitivity Tests; Quinolines; Streptococcus; Thienamycins; Vancomycin | 1987 |
Comparative killing activity and postantibiotic effect of streptomycin combined with ampicillin, ciprofloxacin, imipenem, piperacillin or vancomycin against strains of Streptococcus faecalis and Streptococcus faecium.
Topics: Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Drug Synergism; Enterococcus faecalis; Imipenem; Piperacillin; Streptococcus; Streptomycin; Thienamycins; Vancomycin | 1988 |
Susceptibility of Clostridium difficile strains to new antibiotics: quinolones, efrotomycin, teicoplanin and imipenem.
Topics: Ciprofloxacin; Clostridium; Glycopeptides; Imipenem; Microbial Sensitivity Tests; Pyridones; Quinolines; Teicoplanin; Thienamycins; Vancomycin | 1985 |
Ciprofloxacin therapy of experimental endocarditis caused by methicillin-susceptible or methicillin-resistant Staphylococcus aureus.
Topics: Animals; Ciprofloxacin; Drug Therapy, Combination; Endocarditis, Bacterial; Gentamicins; Humans; Imipenem; Methicillin; Nafcillin; Penicillin Resistance; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Thienamycins; Vancomycin | 1988 |
Comparative efficacies of imipenem-cilastatin and vancomycin in experimental aortic valve endocarditis due to methicillin resistant Staphylococcus aureus.
Topics: Animals; Aortic Valve; Cilastatin; Cilastatin, Imipenem Drug Combination; Cyclopropanes; Drug Combinations; Endocarditis, Bacterial; Heart Valve Diseases; Imipenem; Methicillin; Penicillin Resistance; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Thienamycins; Vancomycin | 1988 |
Imipenem therapy of experimental Staphylococcus epidermidis endocarditis.
Topics: Animals; Endocarditis, Bacterial; Humans; Imipenem; Methicillin; Microbial Sensitivity Tests; Nafcillin; Rabbits; Staphylococcal Infections; Staphylococcus epidermidis; Thienamycins; Vancomycin | 1986 |
In vitro additive effect of imipenem combined with vancomycin against multiple-drug resistant, coagulase-negative Staphylococci.
Topics: Coagulase; Drug Combinations; Drug Resistance, Microbial; Humans; Imipenem; Kinetics; Microbial Sensitivity Tests; Staphylococcus; Staphylococcus aureus; Thienamycins; Vancomycin | 1986 |
In vitro susceptibility of methicillin-resistant Staphylococcus aureus to imipenem and other antimicrobial agents.
Topics: Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Clindamycin; Fusidic Acid; Imipenem; Methicillin; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Penicillin Resistance; Rifampin; Staphylococcus aureus; Thienamycins; Tobramycin; Vancomycin | 1987 |
Bactericidal activity and killing rate of serum against gram-positive cocci in volunteers receiving imipenem, oxacillin, vancomycin or ampicillin plus gentamicin.
Topics: Adult; Ampicillin; Blood Bactericidal Activity; Gentamicins; Gram-Positive Bacteria; Humans; Imipenem; Oxacillin; Penicillin Resistance; Staphylococcus; Streptococcus; Thienamycins; Vancomycin | 1987 |
Comparative activity of CGP 31608, nafcillin, cefamandole, imipenem, and vancomycin against methicillin-susceptible and methicillin-resistant staphylococci.
Topics: Anti-Bacterial Agents; Cefamandole; Imipenem; Lactams; Methicillin; Microbial Sensitivity Tests; Nafcillin; Penicillin Resistance; Staphylococcus; Thienamycins; Vancomycin | 1987 |
Methicillin- and gentamicin-resistant Staphylococcus aureus: susceptibility to fosfomycin, cefamandole, N-formimidoyl-thienamycin, clindamycin, fusidic acid and vancomycin.
Topics: Cefamandole; Clindamycin; Fosfomycin; Fusidic Acid; Gentamicins; Imipenem; Methicillin; Microbial Sensitivity Tests; Penicillin Resistance; Staphylococcus aureus; Thienamycins; Vancomycin | 1985 |
Comparative activity of imipenem (N-formimidoyl thienamycin) on enterococci and its interactions with aminoglycosides.
Topics: Amikacin; Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Drug Combinations; Drug Interactions; Enterococcus faecalis; Imipenem; Microbial Sensitivity Tests; Sisomicin; Streptococcus; Streptomycin; Thienamycins; Vancomycin | 1984 |
Different patterns of bacterial DNA synthesis during postantibiotic effect.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Dicloxacillin; DNA, Bacterial; Escherichia coli; Gentamicins; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Rifampin; Staphylococcus aureus; Tobramycin; Vancomycin | 1995 |
Systemic prophylaxis of experimental staphylococcal endophthalmitis: comparative efficacy of sparfloxacin, pefloxacin, imipenem, vancomycin, and amikacin.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Eye; Eye Infections, Bacterial; Female; Fluoroquinolones; Imipenem; Pefloxacin; Quinolones; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1995 |
Appearance of resistance to beta-lactam antibiotics during therapy for Streptococcus pneumoniae meningitis.
Topics: beta-Lactam Resistance; Cefuroxime; Cephalosporins; Child; Humans; Imipenem; Male; Meningitis, Pneumococcal; Penicillins; Streptococcus pneumoniae; Vancomycin | 1995 |
Infections due to Rhodococcus equi in three HIV-infected patients: microbiological findings and antibiotic susceptibility.
Topics: Actinomycetales Infections; Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Azithromycin; Bacteremia; Bronchoalveolar Lavage Fluid; Clarithromycin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Erythromycin; Female; Gentamicins; HIV Infections; Humans; Imipenem; Male; Pleurisy; Pneumonia, Bacterial; Rhodococcus equi; Rifampin; Sputum; Teicoplanin; Vancomycin | 1994 |
[Rhodococcus equi pneumonia in patients with AIDS].
Topics: Acquired Immunodeficiency Syndrome; Actinomycetales Infections; Adult; Clarithromycin; Erythromycin; Humans; Imipenem; Male; Middle Aged; Pneumonia; Rhodococcus equi; Rifampin; Vancomycin | 1994 |
Comparative efficacies of imipenem, oxacillin and vancomycin for therapy of chronic foreign body infection due to methicillin-susceptible and -resistant Staphylococcus aureus.
Topics: Animals; Chronic Disease; Diffusion Chambers, Culture; Dose-Response Relationship, Drug; Foreign-Body Reaction; Imipenem; Methicillin Resistance; Microbial Sensitivity Tests; Oxacillin; Polytetrafluoroethylene; Prostheses and Implants; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1994 |
Bacteremia in a patient with non-urinary-tract infection due to Corynebacterium urealyticum.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Corynebacterium Infections; Humans; Imipenem; Leukemia, Myeloid; Male; Vancomycin | 1994 |
[Bacteriological evaluation of combined effects of vancomycin and beta-lactams. II. Results against gram-negative rods].
Topics: Anti-Bacterial Agents; Drug Therapy, Combination; Enterobacteriaceae; Gram-Negative Bacteria; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Vancomycin | 1993 |
[Recurrent abscess of the lung caused by Rhodococcus equi in an HIV-positive patient: response to the combination imipenem/vancomycin].
Topics: Actinomycetales Infections; Adult; Drug Therapy, Combination; HIV Seropositivity; Humans; Imipenem; Lung Abscess; Male; Recurrence; Rhodococcus equi; Vancomycin | 1993 |
[Bacteriological evaluations of combination effects with cefotiam and other antimicrobial agents against methicillin-resistant Staphylococcus aureus. I. Synergistic actions of cefotiam with imipenem and vancomycin].
Topics: Cefotiam; Drug Synergism; Drug Therapy, Combination; Imipenem; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus; Vancomycin | 1993 |
Ochrobactrum anthropi bacteremia in a child.
Topics: Bacteremia; Ceftazidime; Child; Drug Therapy, Combination; Female; Gentamicins; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Microbial Sensitivity Tests; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Vancomycin | 1993 |
Fatal encephalitis caused by concomitant infection with tick-borne encephalitis virus and Borrelia burgdorferi.
Topics: Adult; Drug Therapy, Combination; Encephalitis, Tick-Borne; Encephalomyelitis; Humans; Imipenem; Injections, Intravenous; Lyme Disease; Male; Polymerase Chain Reaction; Rifampin; Vancomycin | 1993 |
Effective treatment of multidrug-resistant enterococcal experimental endocarditis with combinations of cell wall-active agents.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Cell Wall; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Endocarditis; Enterococcus faecium; Imipenem; Microbial Sensitivity Tests; Rabbits; Vancomycin | 1996 |
Increased bactericidal activity as documented by serum bactericidal titers for a triple combination of cell wall active agents against gentamicin-resistant enterococci.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Bacteremia; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus faecalis; Female; Gentamicins; Gram-Positive Bacterial Infections; Humans; Imipenem; Penicillins; Serum Bactericidal Test; Thienamycins; Vancomycin | 1995 |
[Nephrotoxicity and drug interaction of vancomycin (2)].
Topics: Animals; Blood Urea Nitrogen; Cefoperazone; Ceftazidime; Cephalosporins; Cilastatin; Cilastatin, Imipenem Drug Combination; Creatinine; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Fosfomycin; Imipenem; Kidney; Male; Organ Size; Rabbits; Vancomycin | 1996 |
[Two cases of gram-positive sepsis successfully treated with vancomycin in combination with imipenem or cilastatin].
Topics: Adolescent; Cilastatin; Drug Therapy, Combination; Female; Gram-Positive Bacterial Infections; Humans; Imipenem; Male; Sepsis; Vancomycin | 1996 |
[Nephrotoxicity and drug interaction of vancomycin].
Topics: Animals; Anti-Bacterial Agents; Cilastatin; Drug Interactions; Drug Therapy, Combination; Imipenem; Kidney; Male; Protease Inhibitors; Rabbits; Thienamycins; Vancomycin | 1996 |
Noncompromised penicillin-resistant pneumococcal pneumonia CBA/J mouse model and comparative efficacies of antibiotics in this model.
Topics: Animals; Anti-Bacterial Agents; Cefotaxime; Disease Models, Animal; Imipenem; Lung; Male; Mice; Mice, Inbred CBA; Mice, Inbred ICR; Microbial Sensitivity Tests; Penicillin G; Penicillin Resistance; Pneumonia, Pneumococcal; Species Specificity; Streptococcus pneumoniae; Vancomycin | 1996 |
Direct application of Etest to gram-positive cocci from blood cultures: quick and reliable minimum inhibitory concentration data.
Topics: Anti-Bacterial Agents; Blood; Cefotaxime; Cephalosporins; Culture Media; Erythromycin; Gentamicins; Gram-Positive Cocci; Imipenem; Microbial Sensitivity Tests; Penicillin G; Penicillins; Thienamycins; Vancomycin | 1996 |
MIC and time-kill study of activities of DU-6859a, ciprofloxacin, levofloxacin, sparfloxacin, cefotaxime, imipenem, and vancomycin against nine penicillin-susceptible and -resistant pneumococci.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Cell Division; Cephalosporins; Drug Resistance, Microbial; Fluoroquinolones; Imipenem; Microbial Sensitivity Tests; Quinolones; Streptococcus pneumoniae; Thienamycins; Time Factors; Vancomycin | 1996 |
Experimental posttraumatic Bacillus cereus endophthalmitis in a swine model. Efficacy of intravitreal ciprofloxacin, vancomycin, and imipenem.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacillaceae Infections; Bacillus cereus; Ciprofloxacin; Disease Models, Animal; Endophthalmitis; Eye Diseases; Eye Infections, Bacterial; Eye Injuries, Penetrating; Imipenem; Pilot Projects; Random Allocation; Retinitis; Swine; Thienamycins; Vancomycin; Vitreous Body | 1996 |
A new selective differential medium for isolation of Stenotrophomonas maltophilia.
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Culture Media; Feces; Humans; Imipenem; Mannitol; Thienamycins; Vancomycin; Xanthomonas | 1996 |
Mixed pulmonary infection with Nocardia, Candida, methicillin-resistant Staphylococcus aureus, and group D Streptococcus species.
Topics: Aged; Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Clotrimazole; Drug Therapy, Combination; Fluconazole; Fusidic Acid; Humans; Imipenem; Immunocompromised Host; Male; Methicillin Resistance; Nocardia Infections; Pneumonia; Pneumonia, Bacterial; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Vancomycin | 1996 |
Pharmacodynamic effects of antibiotics and antibiotic combinations on growing and nongrowing Staphylococcus epidermidis cells.
Topics: Amikacin; Anti-Bacterial Agents; Drug Synergism; Drug Therapy, Combination; Imipenem; Microbial Sensitivity Tests; Ofloxacin; Rifampin; Staphylococcus epidermidis; Vancomycin | 1997 |
Antimicrobial resistance in isolates from inpatients and outpatients in the United States: increasing importance of the intensive care unit.
Topics: Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Enterococcus; Humans; Imipenem; Intensive Care Units; Outpatients; Pseudomonas aeruginosa; Vancomycin | 1997 |
[Optimal antibacterial chemotherapy for infectious diseases associated with hematological malignancies].
Topics: Adult; Aged; Aged, 80 and over; Anemia, Aplastic; Bacterial Infections; Ciprofloxacin; Drug Therapy, Combination; Female; Humans; Imipenem; Leukemia; Lymphoma; Male; Middle Aged; Vancomycin | 1997 |
In-vitro study of the synergy between beta-lactam antibiotics and glycopeptides against enterococci.
Topics: Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Dose-Response Relationship, Drug; Drug Synergism; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Glycopeptides; Imipenem; Microbial Sensitivity Tests; Piperacillin; Teicoplanin; Vancomycin | 1997 |
An evaluation of the bactericidal activity of ampicillin/sulbactam, piperacillin/tazobactam, imipenem or nafcillin alone and in combination with vancomycin against methicillin-resistant Staphylococcus aureus (MRSA) in time-kill curves with infected fibrin
Topics: Ampicillin; Anti-Bacterial Agents; Drug Synergism; Drug Therapy, Combination; Fibrin; Imipenem; Methicillin Resistance; Microbial Sensitivity Tests; Nafcillin; Penicillanic Acid; Penicillins; Piperacillin; Staphylococcus aureus; Sulbactam; Tazobactam; Vancomycin | 1997 |
[Isolation rate of Enterococcus spp. from surgical infections and their susceptibilities].
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Drug Resistance, Microbial; Enterococcus; Humans; Imipenem; Levofloxacin; Ofloxacin; Penicillins; Surgical Wound Infection; Thienamycins; Time Factors; Vancomycin | 1997 |
Comparison of the in-vitro and in-vivo efficacy of FK037, vancomycin, imipenem and nafcillin against staphylococcal species.
Topics: Animals; Bacteriological Techniques; beta-Lactam Resistance; Ceftizoxime; Drug Resistance, Microbial; Endocarditis; Imipenem; Methicillin Resistance; Microbial Sensitivity Tests; Nafcillin; Rabbits; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus; Vancomycin | 1997 |
Decreased susceptibility to imipenem among penicillin-resistant Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Cefotaxime; Imipenem; Meropenem; Microbial Sensitivity Tests; Penicillin Resistance; Rifampin; Streptococcus pneumoniae; Thienamycins; Vancomycin | 1997 |
Therapeutic efficacy of BO-3482, a novel dithiocarbamate carbapenem, in mice infected with methicillin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Carbapenems; Dipeptidases; Imipenem; Kidney; Methicillin Resistance; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Muscle, Skeletal; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1997 |
In vitro evaluation of BO-3482, a novel dithiocarbamate carbapenem with activity against methicillin-resistant staphylococci.
Topics: Anti-Bacterial Agents; Carbapenems; Gram-Positive Bacteria; Imipenem; Kinetics; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus; Vancomycin | 1997 |
[In vitro combination effect of vancomycin and carbapenems against carbapenem-resistant MRSA].
Topics: Anti-Bacterial Agents; Carbapenems; Imipenem; Meropenem; Methicillin Resistance; Staphylococcus aureus; Thienamycins; Vancomycin | 1997 |
Secular trends in bloodstream infection caused by antimicrobial-resistant bacteria in New Jersey hospitals, 1991 to 1995.
Topics: Bacteremia; Cross Infection; Data Collection; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterococcus; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals, Private; Humans; Imipenem; Microbial Sensitivity Tests; New Jersey; Penicillin Resistance; Pneumococcal Infections; Prevalence; Species Specificity; Streptococcus pneumoniae; Vancomycin | 1997 |
Comparative in vitro killing activities of meropenem, imipenem, ceftriaxone, and ceftriaxone plus vancomycin at clinically achievable cerebrospinal fluid concentrations against penicillin-resistant Streptococcus pneumoniae isolates from children with meni
Topics: Anti-Bacterial Agents; Carbapenems; Ceftriaxone; Cephalosporins; Child; Drug Therapy, Combination; Humans; Imipenem; Meningitis, Pneumococcal; Meropenem; Microbial Sensitivity Tests; Penicillin Resistance; Streptococcus pneumoniae; Thienamycins; Vancomycin | 1998 |
High-level aminoglycoside-resistant enterococcus causing endocarditis successfully treated with a combination of ampicillin, imipenem and vancomycin.
Topics: Adult; Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Humans; Imipenem; Microbial Sensitivity Tests; Treatment Outcome; Vancomycin | 1997 |
Effects of fosfomycin and imipenem/cilastatin on nephrotoxicity and renal excretion of vancomycin in rats.
Topics: Animals; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Fosfomycin; Imipenem; Kidney; Male; Metabolic Clearance Rate; Rats; Rats, Wistar; Vancomycin | 1998 |
Penicillin-binding protein 5 sequence alterations in clinical isolates of Enterococcus faecium with different levels of beta-lactam resistance.
Topics: Amino Acid Sequence; Amino Acid Substitution; Ampicillin; Bacterial Proteins; beta-Lactam Resistance; Carrier Proteins; Drug Resistance, Microbial; Enterococcus faecium; Genetic Variation; Gram-Positive Bacterial Infections; Hexosyltransferases; Humans; Imipenem; Microbial Sensitivity Tests; Molecular Sequence Data; Muramoylpentapeptide Carboxypeptidase; Penicillin G; Penicillin Resistance; Penicillin-Binding Proteins; Peptidyl Transferases; Piperacillin; Sequence Homology, Amino Acid; Vancomycin | 1998 |
[Vancomycin-resistant enterococci in pediatric hematology: don't panic!].
Topics: Amikacin; Anemia, Aplastic; Antineoplastic Agents; Bone Marrow Transplantation; Carrier State; Catheterization, Central Venous; Child; Decontamination; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus; Equipment Contamination; Feces; France; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Home Nursing; Hospitalization; Humans; Hygiene; Imipenem; Immunocompromised Host; Mouth; Mouthwashes; Piperacillin; Premedication; Prospective Studies; Transplantation Conditioning; Vancomycin | 1998 |
Molecular characterization of epidemic multiresistant Staphylococcus haemolyticus isolates.
Topics: Ampicillin; Anti-Bacterial Agents; Cefazolin; Cefmetazole; Cross Infection; DNA Restriction Enzymes; Drug Resistance, Microbial; Drug Resistance, Multiple; Electrophoresis, Gel, Pulsed-Field; Gentamicins; Hospital Bed Capacity, 500 and over; Humans; Imipenem; Infant, Newborn; Microbial Sensitivity Tests; Neonatal Nursing; Nursing Staff, Hospital; Ofloxacin; Oxacillin; Phylogeny; Staphylococcal Infections; Staphylococcus; Tobramycin; Vancomycin | 1998 |
Streptococci isolated from various skin lesions: the interaction with Staphylococcus aureus strains.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Erythromycin; Fluoroquinolones; Fusidic Acid; Humans; Imipenem; Microbial Sensitivity Tests; Minocycline; Naphthyridines; Ofloxacin; Penicillins; Skin Diseases, Bacterial; Species Specificity; Streptococcal Infections; Streptococcus; Vancomycin | 1999 |
Effects of fosfomycin and imipenem-cilastatin on the nephrotoxicity of vancomycin and cisplatin in rats.
Topics: Acetylglucosaminidase; Animals; Anti-Bacterial Agents; Antineoplastic Agents; Body Weight; Cilastatin; Cilastatin, Imipenem Drug Combination; Cisplatin; Creatinine; Dose-Response Relationship, Drug; Drug Combinations; Fosfomycin; Glomerular Filtration Rate; Imipenem; Kidney; Male; Nitrogen; Rats; Rats, Wistar; Vancomycin; Weight Gain | 1999 |
Comparison between MRI, microbiology and histology in evaluation of antibiotics in a murine model of thigh infection.
Topics: Animals; Anti-Bacterial Agents; Bacteriological Techniques; Cilastatin; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Therapy, Combination; Evaluation Studies as Topic; Extremities; Histological Techniques; Imipenem; Magnetic Resonance Imaging; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1999 |
Combined effects of vancomycin and imipenem against methicillin-resistant Staphylococcus aureus (MRSA) in vitro and in vivo.
Topics: Animals; Drug Therapy, Combination; Female; Imipenem; Methicillin Resistance; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Neutropenia; Staphylococcus aureus; Vancomycin | 1999 |
In vitro activities of novel trans-3,5-disubstituted pyrrolidinylthio-1beta-methylcarbapenems with potent activities against methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; Carrier Proteins; Coagulase; Colony Count, Microbial; Gram-Negative Bacteria; Gram-Positive Bacteria; Hexosyltransferases; Humans; Imipenem; Methicillin Resistance; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Pseudomonas aeruginosa; Staphylococcus aureus; Thienamycins; Vancomycin | 2000 |
Bacillus cereus fatal bacteremia and apparent association with nosocomial transmission in an intensive care unit.
Topics: Adenocarcinoma; Anti-Bacterial Agents; Bacillus cereus; Bacteremia; Cross Infection; DNA Fingerprinting; DNA, Bacterial; Fatal Outcome; Female; Humans; Imipenem; Intensive Care Units; Lung Neoplasms; Microbial Sensitivity Tests; Middle Aged; Thienamycins; Vancomycin | 2000 |
[Evaluation of the activity and effects of combinations of various antibacterial agents against methicillin-resistant Staphylococcus aureus in vitro].
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Dibekacin; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Imipenem; Methicillin Resistance; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus aureus; Teicoplanin; Vancomycin | 2000 |
Splenic abscesses caused by Actinomyces meyeri in a patient with autoimmune hepatitis.
Topics: Abdominal Abscess; Actinomycosis; Adolescent; Boutonneuse Fever; Diagnosis, Differential; Endocarditis, Bacterial; Female; Gentamicins; Hepatitis, Autoimmune; Humans; Imipenem; Spleen; Vancomycin | 2000 |
[Impediment of cellular immune response under treatment with ticlopidine in a patient with Staphylococcus aureus endocarditis].
Topics: Agranulocytosis; Angioplasty, Balloon, Coronary; Anti-Bacterial Agents; Clarithromycin; Coronary Disease; Drug Therapy, Combination; Echocardiography, Doppler; Endocarditis, Bacterial; Fibrinolytic Agents; Gentamicins; Humans; Imipenem; Immunity, Cellular; Leukocyte Count; Leukocytes; Leukopenia; Male; Middle Aged; Platelet Aggregation Inhibitors; Staphylococcal Infections; Thienamycins; Ticlopidine; Time Factors; Vancomycin | 2000 |
Ability of laboratories to detect emerging antimicrobial resistance in nosocomial pathogens: a survey of project ICARE laboratories.
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Enterococcus faecium; Erythromycin; Humans; Imipenem; Laboratories, Hospital; Meropenem; Ofloxacin; Oxacillin; Penicillins; Pseudomonas aeruginosa; Reproducibility of Results; Serratia marcescens; Staphylococcus aureus; Streptococcus pneumoniae; Thienamycins; Vancomycin | 2000 |
In-vitro activity and killing effect of polycationic peptides on methicillin-resistant Staphylococcus aureus and interactions with clinically used antibiotics.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Drug Interactions; Humans; Imipenem; Methicillin Resistance; Nisin; Peptides, Cyclic; Rana catesbeiana; Rifampin; Staphylococcus aureus; Vancomycin | 2000 |
Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice.
Topics: Animals; Bacteroides; Ciprofloxacin; Colitis; Enterobacteriaceae; Female; HLA-B27 Antigen; Imipenem; Interleukin-1; Metronidazole; Mice; Mice, Inbred BALB C; Rats; Rats, Inbred F344; Vancomycin | 2001 |
A rare infection in a renal transplant recipient.
Topics: Abscess; Anti-Bacterial Agents; Fever; Humans; Imipenem; Kidney Transplantation; Magnetic Resonance Angiography; Male; Microbial Sensitivity Tests; Middle Aged; Nocardia; Nocardia Infections; Postoperative Complications; Roxithromycin; Tomography, X-Ray Computed; Vancomycin | 2001 |
Comparative evaluation of penicillin, ampicillin, and imipenem MICs and susceptibility breakpoints for vancomycin-susceptible and vancomycin-resistant Enterococcus faecalis and Enterococcus faecium.
Topics: Anti-Bacterial Agents; Bacteremia; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Imipenem; Microbial Sensitivity Tests; Penicillins; Vancomycin; Vancomycin Resistance | 2001 |
[In vitro and in vivo activities of panipenem against penicillin-resistant Streptococcus pneumoniae].
Topics: Ampicillin; Animals; beta-Alanine; Cefozopran; Ceftriaxone; Cephalosporins; Cilastatin; Cilastatin, Imipenem Drug Combination; Disease Models, Animal; Drug Combinations; Drug Resistance; Imipenem; Male; Meropenem; Mice; Mice, Inbred Strains; Penicillin Resistance; Pneumonia, Pneumococcal; Streptococcus pneumoniae; Thienamycins; Vancomycin | 2001 |
Recurrent bacteremia caused by Rhodococcus equi in a non-neutropenic patient with acute myeloid leukemia in complete remission.
Topics: Actinomycetales Infections; Adult; Amikacin; Bacteremia; Catheters, Indwelling; Ceftazidime; Cilastatin; Drug Resistance; Drug Therapy, Combination; Erythromycin; Female; Humans; Imipenem; Immunocompromised Host; Leukemia, Myelomonocytic, Acute; Neutropenia; Pneumonia, Bacterial; Recurrence; Rhodococcus equi; Vancomycin | 2002 |
Minimal inhibitory concentrations and time-kill determination of moxifloxacin against aerobic and anaerobic isolates.
Topics: Aerobiosis; Anaerobiosis; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Bacteria; Ceftriaxone; Cephalosporins; Ciprofloxacin; Clindamycin; Clostridium; Drug Resistance, Multiple, Bacterial; Erythromycin; Fluoroquinolones; Imipenem; Microbial Sensitivity Tests; Moxifloxacin; Mycoplasma; Quinolines; Streptococcus; Teicoplanin; Thienamycins; Vancomycin | 2002 |
Staphylococcus heterogeneously resistant to vancomycin in China and antimicrobial activities of imipenem and vancomycin in combination against it.
Topics: Drug Therapy, Combination; Imipenem; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus; Vancomycin; Vancomycin Resistance | 2002 |
Pseudomembranous tracheobronchitis caused by methicillin-resistant Staphylococcus aureus.
Topics: Aged; Anti-Bacterial Agents; Bronchi; Bronchitis; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Humans; Imipenem; Influenza, Human; Male; Methicillin; Methicillin Resistance; Respiratory Distress Syndrome; Staphylococcal Infections; Staphylococcus aureus; Trachea; Tracheitis; Vancomycin | 2002 |
Facial and periorbital cellulitis with orbital involvement.
Topics: Adult; Cellulitis; Drug Therapy, Combination; Eyelid Diseases; Facial Dermatoses; Female; Follow-Up Studies; Humans; Imipenem; Infusions, Intravenous; Orbital Diseases; Risk Assessment; Severity of Illness Index; Tomography, X-Ray Computed; Treatment Outcome; Vancomycin | 2002 |
The in vitro elution characteristics of vancomycin combined with imipenem-cilastatin in acrylic bone-cements: a pharmacokinetic study.
Topics: Acrylic Resins; Biological Availability; Bone Cements; Cilastatin; Drug Delivery Systems; Drug Therapy, Combination; Imipenem; In Vitro Techniques; Solubility; Vancomycin | 2002 |
Two-component system VraSR positively modulates the regulation of cell-wall biosynthesis pathway in Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Bacitracin; Bacterial Proteins; beta-Lactam Resistance; Ceftizoxime; Cell Wall; DNA-Binding Proteins; Drug Resistance, Multiple, Bacterial; Fosfomycin; Gene Expression Profiling; Gene Expression Regulation, Bacterial; Imipenem; Methicillin Resistance; Microbial Sensitivity Tests; Oligonucleotide Array Sequence Analysis; Oxacillin; Receptors, Cell Surface; RNA, Bacterial; RNA, Messenger; Staphylococcus aureus; Teicoplanin; Transcription, Genetic; Vancomycin | 2003 |
Severe Chlamydia pneumoniae infection in a patient with mild neutropenia during treatment of Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Aza Compounds; Bleomycin; Chlamydophila Infections; Chlamydophila pneumoniae; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Female; Fluoroquinolones; Hodgkin Disease; Humans; Imipenem; Immunocompromised Host; Moxifloxacin; Neutropenia; Pneumonia, Bacterial; Quinolines; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin; Vincristine | 2004 |
Association between antecedent intravenous antimicrobial exposure and isolation of vancomycin-resistant enterococci.
Topics: Adult; Aged; Anti-Bacterial Agents; Case-Control Studies; Ceftazidime; Cross Infection; Enterococcus; Female; Gram-Positive Bacterial Infections; Hospitals, Urban; Humans; Imipenem; Infusions, Intravenous; Male; Middle Aged; Severity of Illness Index; Vancomycin; Vancomycin Resistance | 2003 |
[Characteristics of bacteriology and drug sensitivity in patients with COPD combined with pneumonia].
Topics: Adult; Aged; Amikacin; Bacteria; Female; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia; Pulmonary Disease, Chronic Obstructive; Vancomycin | 2003 |
Increasing prevalence of vancomycin-resistant Enterococcus faecium, expanded-spectrum cephalosporin-resistant Klebsiella pneumoniae, and imipenem-resistant Pseudomonas aeruginosa in Korea: KONSAR study in 2001.
Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Microbial; Enterococcus faecium; Humans; Imipenem; Klebsiella pneumoniae; Korea; Pseudomonas aeruginosa; Time Factors; Vancomycin | 2004 |
Intravitreal vancomycin and amikacin versus intravenous imipenem in the treatment of experimental Staphylococcus aureus endophthalmitis.
Topics: Amikacin; Animals; Disease Models, Animal; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Imipenem; Injections, Intravenous; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vitreous Body | 2004 |
[Investigation on the drug resistance of Pseudomonas aeruginosa in our burn ward in the past 11 years].
Topics: Amikacin; Anti-Bacterial Agents; Burn Units; Ceftazidime; Drug Administration Schedule; Drug Resistance, Bacterial; Humans; Imipenem; Penicillins; Pseudomonas aeruginosa; Vancomycin | 2004 |
[Sensitivity of MRSA isolated in our hospital to various antibacterial agents: changes over 5 years].
Topics: Aminoglycosides; Coagulase; Dibekacin; Drug Resistance, Bacterial; Enterotoxins; Humans; Imipenem; Methicillin Resistance; Netilmicin; Ofloxacin; Staphylococcus aureus; Teicoplanin; Vancomycin | 2004 |
Characteristics of opportunistic species of the Corynebacterium and related coryneforms isolated from different clinical materials.
Topics: Anti-Bacterial Agents; Corynebacterium; Corynebacterium Infections; Drug Resistance, Bacterial; Female; Humans; Imipenem; Male; Microbial Sensitivity Tests; Teicoplanin; Vancomycin | 2003 |
Emerging bacterial resistance patterns in febrile neutropenic patients: experience at a tertiary care hospital in Pakistan.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cloxacillin; Drug Resistance, Bacterial; Fever; Gram-Negative Bacteria; Gram-Positive Bacteria; Hematologic Neoplasms; Hospitals, University; Humans; Imipenem; Leukemia; Microbial Sensitivity Tests; Neutropenia; Pakistan; Retrospective Studies; Vancomycin | 2004 |
RNAIII-inhibiting peptide improves efficacy of clinically used antibiotics in a murine model of staphylococcal sepsis.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; Cefazolin; Colony Count, Microbial; Disease Models, Animal; Drug Synergism; Imipenem; Male; Mice; Mice, Inbred BALB C; Oligopeptides; Random Allocation; Sensitivity and Specificity; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Time Factors; Vancomycin | 2005 |
[Analysis of the distribution characteristics and drug sensitivity of infection pathogens in hematology department ward].
Topics: Cross Infection; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Hematologic Diseases; Humans; Imipenem; Microbial Sensitivity Tests; Vancomycin | 2004 |
RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; Biofilms; Catheterization, Central Venous; Catheters, Indwelling; Ciprofloxacin; Drug Therapy, Combination; Imipenem; Male; Microbial Sensitivity Tests; Oligopeptides; Rats; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2006 |
Further increase of vancomycin-resistant Enterococcus faecium, amikacin- and fluoroquinolone-resistant Klebsiella pneumoniae, and imipenem-resistant Acinetobacter spp. in Korea: 2003 KONSAR surveillance.
Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus faecium; Fluoroquinolones; Gammaproteobacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Korea; Microbial Sensitivity Tests; Population Surveillance; Vancomycin; Vancomycin Resistance | 2006 |
Necrotizing gastritis due to Bacillus cereus in an immunocompromised patient.
Topics: Adult; Anti-Bacterial Agents; Bacillaceae Infections; Bacillus cereus; Female; Gastritis; Humans; Imipenem; Immunocompromised Host; Leukemia, Myeloid, Acute; Necrosis; Treatment Outcome; Vancomycin | 2006 |
[Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004). I. Susceptibility distribution].
Topics: Aminoglycosides; Ampicillin; Anti-Infective Agents; Aztreonam; Cefixime; Cefozopran; Cefpirome; Cefpodoxime; Ceftizoxime; Cephalosporins; Dibekacin; Drug Resistance, Bacterial; Enterococcus faecalis; Escherichia coli; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Proteus mirabilis; Pseudomonas aeruginosa; Quinolones; Serratia marcescens; Staphylococcus aureus; Thienamycins; Urinary Tract Infections; Vancomycin | 2006 |
In vitro activity effects of combinations of cephalothin, dicloxacillin, imipenem, vancomycin and amikacin against methicillin-resistant Staphylococcus spp. strains.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Cephalothin; Dicloxacillin; Drug Synergism; Drug Therapy, Combination; Electrophoresis, Gel, Pulsed-Field; Humans; Imipenem; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus; Staphylococcus aureus; Vancomycin | 2006 |
Giant subdural empyema in a child: a case report.
Topics: Anti-Bacterial Agents; Craniotomy; Drug Therapy, Combination; Empyema, Subdural; Female; Frontal Lobe; Humans; Imipenem; Infant; Magnetic Resonance Imaging; Parietal Lobe; Streptococcal Infections; Streptococcus pneumoniae; Tomography, X-Ray Computed; Vancomycin | 2006 |
Ertapenem resistance of Escherichia coli.
Topics: Anti-Bacterial Agents; Antifungal Agents; beta-Lactams; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Fluconazole; Gentamicins; Humans; Imipenem; Immunocompromised Host; Middle Aged; Vancomycin | 2007 |
In vitro antibacterial activities of tigecycline and comparative agents by time-kill kinetic studies in fresh Mueller-Hinton broth.
Topics: Anti-Bacterial Agents; Culture Media; Drug Resistance, Bacterial; Gram-Negative Aerobic Rods and Cocci; Gram-Positive Cocci; Humans; Imipenem; Microbial Sensitivity Tests; Minocycline; Tigecycline; Vancomycin | 2007 |
[Sepsis in the sphenoiditis patient].
Topics: Abscess; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Female; Humans; Imipenem; Middle Aged; Radiography; Sepsis; Sphenoid Sinus; Sphenoid Sinusitis; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2007 |
Spontaneous bacterial peritonitis in terminal renal failure.
Topics: Adult; Anti-Bacterial Agents; Ascites; Cefotaxime; Drug Therapy, Combination; Humans; Imipenem; Kidney Failure, Chronic; Male; Peritonitis; Renal Dialysis; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 2007 |
Impact of antibiotic restriction on broad spectrum antibiotic usage in the ICU of a developing country.
Topics: Anti-Bacterial Agents; Cefepime; Cephalosporins; Developing Countries; Drug Prescriptions; Drug Resistance, Microbial; Drug Utilization Review; Humans; Imipenem; Intensive Care Units; Medical Order Entry Systems; Organizational Policy; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Polymyxin B; Program Development; Vancomycin | 2007 |
Simultaneous determination of cefepime, vancomycin and imipenem in human plasma of burn patients by high-performance liquid chromatography.
Topics: Adolescent; Anti-Bacterial Agents; Burns; Calibration; Cefepime; Cephalosporins; Chromatography, High Pressure Liquid; Drug Monitoring; Female; Humans; Imipenem; Male; Middle Aged; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Vancomycin | 2007 |
Late bacterial keratitis after intracorneal ring segments (Ferrara ring) insertion for keratoconus.
Topics: Adult; Anti-Bacterial Agents; Aza Compounds; Corneal Stroma; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Humans; Imipenem; Keratoconus; Microbial Sensitivity Tests; Moxifloxacin; Postoperative Complications; Prostheses and Implants; Prosthesis Implantation; Quinolines; Staphylococcal Infections; Vancomycin | 2007 |
Effects of intravitreal corticosteroid in the treatment of Staphylococcus aureus-induced experimental endophthalmitis.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Dexamethasone; Disease Models, Animal; Drug Therapy, Combination; Electroretinography; Endophthalmitis; Eye Infections, Bacterial; Female; Glucocorticoids; Imipenem; Injections; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vitreous Body | 2008 |
Serious postpartum infection due to MRSA in an asymptomatic carrier: case report and review.
Topics: Abscess; Anti-Bacterial Agents; Anticoagulants; Carrier State; Cesarean Section; Cilastatin; Cilastatin, Imipenem Drug Combination; Drainage; Drug Combinations; Female; Heparin; Humans; Imipenem; Methicillin-Resistant Staphylococcus aureus; Pregnancy; Puerperal Infection; Pulmonary Embolism; Radiography; Sepsis; Staphylococcal Infections; Surgical Wound Infection; Thrombophlebitis; Vancomycin; Young Adult | 2008 |
Imipenem-resistant Pseudomonas aeruginosa: risk factors for nosocomial infections.
Topics: Adult; Aged; Anti-Bacterial Agents; Case-Control Studies; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Imipenem; Length of Stay; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Vancomycin | 2008 |
Surveillance of intrahospital infections at the clinic for gynaecology and obstetrics.
Topics: Anti-Bacterial Agents; Bosnia and Herzegovina; Cefepime; Cephalosporins; Cross Infection; Female; Humans; Imipenem; Klebsiella pneumoniae; Obstetrics and Gynecology Department, Hospital; Population Surveillance; Prevalence; Prospective Studies; Proteus mirabilis; Pseudomonas aeruginosa; Staphylococcus aureus; Streptococcus; Surgical Wound Infection; Urinary Tract Infections; Vancomycin | 2009 |
Imipenem/cilastatin with or without glycopeptide as initial antibiotic therapy for recipients of autologous stem cell transplantation: results of a Spanish multicenter study.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Cilastatin; Disease-Free Survival; Female; Glycopeptides; Hematologic Neoplasms; Humans; Imipenem; Male; Middle Aged; Neutropenia; Protease Inhibitors; Retrospective Studies; Spain; Stem Cell Transplantation; Survival Rate; Teicoplanin; Transplantation, Autologous; Vancomycin | 2009 |
High imipenem blood concentrations associated with toxic encephalopathy in a patient with mild renal dysfunction.
Topics: Aged; Anti-Bacterial Agents; Catheter-Related Infections; Enterocolitis; Fatal Outcome; Female; Humans; Imipenem; Kidney Diseases; Neurotoxicity Syndromes; Sepsis; Staphylococcal Infections; Staphylococcus haemolyticus; Vancomycin | 2009 |
Pyogenic liver abscess associated with a gastrointestinal stromal tumor of the stomach.
Topics: Aged; Anti-Bacterial Agents; Antineoplastic Agents; Benzamides; Combined Modality Therapy; Diagnosis, Differential; Drainage; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Imipenem; Liver Abscess, Pyogenic; Male; Piperazines; Pyrimidines; Streptococcal Infections; Tomography, X-Ray Computed; Vancomycin | 2010 |
In vitro and in vivo activities of linezolid alone and combined with vancomycin and imipenem against Staphylococcus aureus with reduced susceptibility to glycopeptides.
Topics: Acetamides; Animals; Ascitic Fluid; Bacteremia; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Glycopeptides; Imipenem; Linezolid; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Oxazolidinones; Peritonitis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2010 |
Neonatal community-acquired pneumonia: pathogens and treatment.
Topics: Anti-Bacterial Agents; China; Community-Acquired Infections; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Infant, Newborn; Male; Meropenem; Microbial Sensitivity Tests; Pneumonia, Bacterial; Retrospective Studies; Sputum; Thienamycins; Vancomycin | 2010 |
[Antibiotic susceptibility of blood-borne Streptococcus pneumoniae and efficacy assessment of respiratory quinolones using Monte Carlo simulation].
Topics: Anti-Bacterial Agents; Blood; Drug Resistance, Bacterial; Fluoroquinolones; Genotype; Humans; Imipenem; Meropenem; Monte Carlo Method; Mutation; Penicillin-Binding Proteins; Streptococcus pneumoniae; Thienamycins; Vancomycin | 2010 |
Efficacy of fosfomycin and its combination with linezolid, vancomycin and imipenem in an experimental peritonitis model caused by a Staphylococcus aureus strain with reduced susceptibility to vancomycin.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Ascitic Fluid; Bacteremia; Bacterial Load; Disease Models, Animal; Drug Therapy, Combination; Female; Fosfomycin; Humans; Imipenem; Linezolid; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Oxazolidinones; Peritonitis; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2011 |
Emergence of fluoroquinolone-resistant Streptococcus pneumoniae in Lebanon: a report of three cases.
Topics: Aged; Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Clarithromycin; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Lebanon; Levofloxacin; Male; Ofloxacin; Pneumococcal Infections; Pneumonia, Pneumococcal; Streptococcus pneumoniae; Vancomycin | 2010 |
Increase of ceftazidime- and fluoroquinolone-resistant Klebsiella pneumoniae and imipenem-resistant Acinetobacter spp. in Korea: analysis of KONSAR study data from 2005 and 2007.
Topics: Acinetobacter; Bacterial Infections; Ceftazidime; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Fluoroquinolones; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Methicillin-Resistant Staphylococcus aureus; Pseudomonas aeruginosa; Republic of Korea; Vancomycin | 2010 |
Peritonitis after gynecological and gastroscopic examinations in a peritoneal dialysis patient.
Topics: Amikacin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Enterococcus; Female; Gastroscopy; Gynecological Examination; Humans; Imipenem; Middle Aged; Peritoneal Dialysis; Peritonitis; Secondary Prevention; Treatment Outcome; Vancomycin | 2010 |
Absence of keratin 8 confers a paradoxical microflora-dependent resistance to apoptosis in the colon.
Topics: Animals; Anti-Bacterial Agents; Antibodies; Apoptosis; Cell Line; Cell Proliferation; Cells, Cultured; Colon; Drug Resistance; Female; Focal Adhesion Kinase 1; Gene Expression Profiling; Imipenem; Immunoblotting; In Situ Nick-End Labeling; Inhibitor of Apoptosis Proteins; Integrin beta4; Keratin-8; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Phosphorylation; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; Survivin; Vancomycin | 2011 |
Evaluation of the synergistic potential of vancomycin combined with other antimicrobial agents against methicillin-resistant Staphylococcus aureus and coagulase-negative Staphylococcus spp strains.
Topics: Anti-Bacterial Agents; Coagulase; Drug Synergism; Humans; Imipenem; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcus; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2011 |
[Upper gastrointestinal bleeding due to secondary aortoenteric fistula].
Topics: Aged, 80 and over; Anti-Bacterial Agents; Aortic Aneurysm, Abdominal; Aortic Diseases; Aortic Rupture; Aortitis; Blood Vessel Prosthesis Implantation; Comorbidity; Contrast Media; Drug Therapy, Combination; Fatal Outcome; Gastroenterostomy; Gastrointestinal Hemorrhage; Hematemesis; Humans; Imipenem; Intestinal Fistula; Male; Postoperative Complications; Prosthesis-Related Infections; Tomography, X-Ray Computed; Vancomycin; Vascular Fistula | 2011 |
Imipenem-induced Clostridium difficile diarrhea in a patient with chronic renal failure.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Imipenem; Kidney Failure, Chronic; Male; Pneumonia; Vancomycin | 2011 |
The impact of a nationwide antibiotic restriction program on antibiotic usage and resistance against nosocomial pathogens in Turkey.
Topics: Acinetobacter; Anti-Bacterial Agents; Cefepime; Ceftazidime; Ceftriaxone; Cephalosporins; Cost Savings; Cross Infection; Drug Costs; Drug Prescriptions; Drug Resistance, Bacterial; Drug Utilization; Escherichia; Health Policy; Hospitals; Humans; Imipenem; Klebsiella; Meropenem; Methicillin Resistance; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas; Staphylococcus aureus; Teicoplanin; Thienamycins; Turkey; Vancomycin | 2011 |
Identification of Stenotrophomonas maltophilia strains isolated from environmental and clinical samples: a rapid and efficient procedure.
Topics: Agar; Amphotericin B; Culture Media; DNA, Bacterial; DNA, Ribosomal; Humans; Imipenem; Multiplex Polymerase Chain Reaction; RNA, Ribosomal, 16S; RNA, Ribosomal, 23S; Sequence Analysis, DNA; Soil Microbiology; Stenotrophomonas maltophilia; Vancomycin | 2011 |
Heterogeneously vancomycin-intermediate Staphylococcus aureus (hVISA) emerged before the clinical introduction of vancomycin in Japan: a retrospective study.
Topics: Anti-Bacterial Agents; Communicable Diseases, Emerging; Humans; Imipenem; Japan; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2012 |
[Antibiotic susceptibility of isolates from blood of patients in intensive care units of emergency medical service].
Topics: Acetamides; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Candida; Cross Infection; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Infection Control; Intensive Care Units; Linezolid; Meropenem; Moscow; Oxazolidinones; Sepsis; Thienamycins; Vancomycin | 2011 |
Comparative assessment of antimicrobial usage measures in the Department of Veterans Affairs.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Utilization Review; Hospitals, Veterans; Humans; Imipenem; Meropenem; Penicillanic Acid; Pilot Projects; Piperacillin; Piperacillin, Tazobactam Drug Combination; Thienamycins; United States; Vancomycin | 2012 |
[Microbiological monitoring in therapy of patients with iatrogenic esophageotracheal fistula].
Topics: Acetamides; Anti-Bacterial Agents; Candida; Cefepime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Enterobacteriaceae; Follow-Up Studies; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Iatrogenic Disease; Imipenem; Intubation, Intratracheal; Linezolid; Microbial Sensitivity Tests; Monitoring, Physiologic; Oxazolidinones; Polymyxin B; Pseudomonas aeruginosa; Respiratory Tract Infections; Staphylococcus aureus; Staphylococcus epidermidis; Tracheoesophageal Fistula; Vancomycin | 2012 |
Antibiotic selection for the treatment of infectious complications of implant-based breast reconstruction.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Breast Implantation; Breast Implants; Device Removal; Drainage; Drug Resistance, Bacterial; Female; Fluoroquinolones; Free Tissue Flaps; Gentamicins; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Injections, Intravenous; Microbial Sensitivity Tests; Middle Aged; Radiography, Interventional; Reoperation; Retrospective Studies; Surgical Wound Infection; Tissue Expansion Devices; Treatment Outcome; Vancomycin | 2013 |
Methicillin-resistant coagulase-negative staphylococci (MRCoNS) by disk diffusion method.
Topics: Anti-Bacterial Agents; Ceftriaxone; Cefuroxime; Ciprofloxacin; Coagulase; Drug Resistance, Multiple, Bacterial; Exudates and Transudates; Gentamicins; Humans; Imipenem; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxacillin; Staphylococcal Infections; Suppuration; Surgical Wound Infection; Vancomycin | 2013 |
[Infective endocarditis by Rhizobium radiobacter. A case report].
Topics: Agrobacterium tumefaciens; Anti-Bacterial Agents; Bacteremia; Catheter-Related Infections; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Endocarditis, Bacterial; Equipment Contamination; Gram-Negative Bacterial Infections; Humans; Imipenem; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Subclavian Vein; Tricuspid Valve Insufficiency; Vancomycin | 2013 |
[Endogenous endophthalmitis as a complication in erysipelas].
Topics: Antifungal Agents; Bacteremia; Ceftazidime; Diabetes Mellitus, Type 2; Disease Susceptibility; Drug Therapy, Combination; Endophthalmitis; Erysipelas; Eye Infections, Bacterial; Humans; Imipenem; Intertrigo; Leg; Levofloxacin; Male; Middle Aged; Obesity; Streptococcus agalactiae; Uveitis, Anterior; Vancomycin | 2013 |
Antibiotic overuse and Clostridium difficile: a teachable moment.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Clindamycin; Clostridioides difficile; Enterocolitis, Pseudomembranous; Fasciitis, Necrotizing; Fatal Outcome; Female; Humans; Imipenem; Inappropriate Prescribing; Streptococcal Infections; Streptococcus pyogenes; Vancomycin | 2014 |
Exposure of Staphylococcus aureus to subinhibitory concentrations of β-lactam antibiotics induces heterogeneous vancomycin-intermediate Staphylococcus aureus.
Topics: Anti-Bacterial Agents; beta-Lactams; Ceftazidime; Ceftriaxone; Drug Resistance, Bacterial; Imipenem; Methicillin Resistance; Microbial Sensitivity Tests; Microscopy, Electron, Transmission; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2014 |
Endogenous endophthalmitis in a patient with diabetes and foot osteomyelitis.
Topics: Aged; Anti-Bacterial Agents; Ciprofloxacin; Diabetes Complications; Diabetes Mellitus; Endophthalmitis; Female; Foot Diseases; Humans; Imipenem; Osteomyelitis; Radiography; Vancomycin | 2015 |
Endothelial Cell Toxicity of Vancomycin Infusion Combined with Other Antibiotics.
Topics: Anti-Bacterial Agents; Cell Death; Cells, Cultured; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Erythromycin; Gentamicins; Human Umbilical Vein Endothelial Cells; Humans; Imipenem; Infusions, Intravenous; Vancomycin | 2015 |
Japanese nationwide surveillance in 2011 of antibacterial susceptibility patterns of clinical isolates from complicated urinary tract infection cases.
Topics: Aged; Aged, 80 and over; Amikacin; Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Escherichia coli; Female; Fluoroquinolones; Gram-Negative Bacteria; Humans; Imipenem; Japan; Klebsiella oxytoca; Klebsiella pneumoniae; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Population Surveillance; Proteus mirabilis; Pseudomonas aeruginosa; Serratia marcescens; Urinary Tract Infections; Vancomycin | 2015 |
Efficacy of Single and Combined Antibiotic Treatments of Anthrax in Rabbits.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anthrax; Anti-Bacterial Agents; Bacillus anthracis; Bacteremia; Ciprofloxacin; Clarithromycin; Disease Models, Animal; Doxycycline; Drug Combinations; Drug Synergism; Humans; Imipenem; Linezolid; Male; Microbial Sensitivity Tests; Rabbits; Respiratory Tract Infections; Rifampin; Spores, Bacterial; Survival Analysis; Vancomycin | 2015 |
Fosfomycin plus β-Lactams as Synergistic Bactericidal Combinations for Experimental Endocarditis Due to Methicillin-Resistant and Glycopeptide-Intermediate Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Aortic Valve; Area Under Curve; Ceftriaxone; Drug Administration Schedule; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Endocarditis, Bacterial; Fosfomycin; Gene Expression; Imipenem; Infusion Pumps; Methicillin-Resistant Staphylococcus aureus; Penicillin-Binding Proteins; Protein Isoforms; Rabbits; Staphylococcal Infections; Vancomycin | 2016 |
Observations of resistance through minimum inhibitory concentrations trends for respiratory specimens of commonly isolated organisms.
Topics: Acinetobacter; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Imipenem; Intensive Care Units; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Respiratory Tract Infections; Retrospective Studies; Staphylococcus aureus; Vancomycin | 2016 |
Inhibition of LpxC Increases Antibiotic Susceptibility in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amidohydrolases; Amikacin; Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; Carbapenems; Drug Resistance, Multiple, Bacterial; Imipenem; Microbial Sensitivity Tests; Minocycline; Rifampin; Tigecycline; Vancomycin | 2016 |
Photo Quiz: A 44-Year-Old Kidney Transplant Patient with Pneumonia.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; beta-Lactamases; Clostridioides difficile; Enterobacter cloacae; Female; Humans; Imipenem; Kidney Failure, Chronic; Kidney Transplantation; Metronidazole; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia; Respiratory Insufficiency; Vancomycin | 2017 |
Vancomycin and Ceftazidime in Bone Cement as a Potentially Effective Treatment for Knee Periprosthetic Joint Infection.
Topics: Aged; Anti-Bacterial Agents; Aztreonam; Bone Cements; Ceftazidime; Chronic Disease; Female; Humans; Imipenem; Knee Prosthesis; Male; Middle Aged; Prosthesis-Related Infections; Teicoplanin; Treatment Outcome; Vancomycin | 2017 |
Clinical Outcome and Antimicrobial Therapeutic Drug Monitoring for the Treatment of Infections in Acute Burn Patients.
Topics: Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Burns; Child; Child, Preschool; Cross Infection; Drug Monitoring; Female; Humans; Imipenem; Infant; Intensive Care Units; Male; Meropenem; Middle Aged; Piperacillin; Pneumonia; Prognosis; Tertiary Care Centers; Thienamycins; Urinary Tract Infections; Vancomycin; Young Adult | 2017 |
A Human Biofilm-Disrupting Monoclonal Antibody Potentiates Antibiotic Efficacy in Rodent Models of both Staphylococcus aureus and Acinetobacter baumannii Infections.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aortic Valve; Biofilms; Drug Therapy, Combination; Endocarditis; Epitopes; Female; Humans; Imipenem; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Rats; Rats, Sprague-Dawley; Staphylococcal Infections; Vancomycin | 2017 |
Analysis of distribution and antibiotic resistance of pathogens isolated from the paediatric population in Shenmu Hospital from 2011-2015.
Topics: Ampicillin; Anti-Bacterial Agents; Antifungal Agents; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Erythromycin; Female; Fungi; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Imipenem; Infant; Infant, Newborn; Male; Meropenem; Microbial Sensitivity Tests; Mycoses; Penicillins; Retrospective Studies; Thienamycins; Vancomycin | 2018 |
Co-administration of vancomycin and piperacillin-tazobactam is associated with increased renal dysfunction in adult and pediatric burn patients.
Topics: Acute Kidney Injury; Adolescent; Adult; Analysis of Variance; Anti-Bacterial Agents; Burns; Child; Child, Preschool; Cilastatin; Cilastatin, Imipenem Drug Combination; Cohort Studies; Creatinine; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Incidence; Infections; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Texas; Vancomycin | 2017 |
A decision support system for antibiotic prescription based on local cumulative antibiograms.
Topics: Algorithms; Anti-Bacterial Agents; Antimicrobial Stewardship; Decision Support Systems, Clinical; Electronic Health Records; Hospitals; Humans; Imipenem; Linezolid; Meropenem; Microbial Sensitivity Tests; Prescriptions; Reproducibility of Results; Software; Vancomycin | 2018 |
The first isolation of Clostridium difficile RT078/ST11 from pigs in China.
Topics: Animals; Anti-Bacterial Agents; Cefotaxime; Cefoxitin; Chickens; China; Ciprofloxacin; Clostridioides difficile; Ducks; Imipenem; Metronidazole; Molecular Epidemiology; Multilocus Sequence Typing; Polymerase Chain Reaction; Ribotyping; Swine; Tetracycline; Vancomycin | 2019 |
The pathogen spectrum and resistance in patients with peritoneal dialysis-associated peritonitis: A single-center, observational clinical study
.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antifungal Agents; Bacterial Infections; Cefazolin; Ceftriaxone; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Imipenem; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Peritoneal Dialysis; Peritonitis; Vancomycin; Voriconazole; Young Adult | 2019 |
In vitro activities of imipenem, vancomycin, and rifampicin against clinical Elizabethkingia species producing BlaB and GOB metallo-beta-lactamases.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Drug Resistance, Bacterial; Edetic Acid; Flavobacteriaceae; Flavobacteriaceae Infections; Humans; Imipenem; Microbial Sensitivity Tests; Phylogeny; Rifampin; Species Specificity; Vancomycin | 2019 |
Topics: Anti-Bacterial Agents; Daptomycin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Imipenem; Linezolid; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Penicillins; Staphylococcal Infections; Vancomycin | 2020 |
Outcome and Adequacy of Empirical Antibiotherapy in Post-Operative Peritonitis: A Retrospective Study.
Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Anastomotic Leak; Anti-Bacterial Agents; Ascitic Fluid; Clavulanic Acids; Cohort Studies; Culture Techniques; Digestive System Surgical Procedures; Disk Diffusion Antimicrobial Tests; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Hospital Mortality; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Peritonitis; Piperacillin, Tazobactam Drug Combination; Postoperative Complications; Prognosis; Retrospective Studies; Surgical Wound Infection; Ticarcillin; Treatment Outcome; Vancomycin | 2020 |
Effective treatment of single-stage revision using intra-articular antibiotic infusion for culture-negative prosthetic joint infection.
Topics: Anti-Bacterial Agents; Arthritis, Infectious; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Bacteria; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Hip Joint; Humans; Imipenem; Injections, Intra-Articular; Knee Joint; Male; Middle Aged; Postoperative Care; Prosthesis-Related Infections; Reoperation; Retrospective Studies; Time Factors; Treatment Outcome; Vancomycin | 2020 |
Susceptibility patterns of anaerobes isolated from clinical specimens in tertiary Hospital, Malaysia.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Bacteroides fragilis; Clindamycin; Drug Resistance, Bacterial; Humans; Imipenem; Malaysia; Metronidazole; Microbial Sensitivity Tests; Tertiary Care Centers; Vancomycin | 2020 |
Maternal antibiotic administration during a critical developmental window has enduring neurobehavioural effects in offspring mice.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Anxiety; Ciprofloxacin; Cognition; Female; Homing Behavior; Imipenem; Male; Metronidazole; Mice; Mice, Inbred C57BL; Penicillin V; Pregnancy; Prenatal Exposure Delayed Effects; Social Behavior; Vancomycin; Vocalization, Animal | 2021 |
Synergistic effect of vancomycin combined with cefotaxime, imipenem, or meropenem against Staphylococcus aureus with reduced susceptibility to vancomycin
Topics: Anti-Bacterial Agents; beta-Lactams; Cefotaxime; Drug Synergism; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2021 |
Dual drug delivery of vancomycin and imipenem/cilastatin by coaxial nanofibers for treatment of diabetic foot ulcer infections.
Topics: Anti-Bacterial Agents; Cilastatin; Diabetes Mellitus; Diabetic Foot; Drug Liberation; Escherichia coli; Humans; Imipenem; Methicillin-Resistant Staphylococcus aureus; Nanofibers; Pharmaceutical Preparations; Staphylococcus aureus; Vancomycin | 2021 |
Effectiveness and antimicrobial susceptibility profiles during primary antimicrobial prophylaxis for pediatric acute myeloid leukemia.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Antifungal Agents; Bacteremia; Child; Ciprofloxacin; Febrile Neutropenia; Female; Humans; Imipenem; Leukemia, Myeloid, Acute; Male; Mycoses; Vancomycin; Voriconazole | 2021 |
Hemoperfusion with Seraph 100 Microbind Affinity Blood Filter Unlikely to Require Increased Antibiotic Dosing: A Simulations Study Using a Pharmacokinetic/Pharmacodynamic Approach.
Topics: Anti-Bacterial Agents; Critical Illness; Gentamicins; Hemoperfusion; Humans; Imipenem; Meropenem; Vancomycin | 2023 |
The evaluation of antibiotic susceptibility pattern and associated risk factors of UTI in tertiary care hospital of Peshawar.
Topics: Amikacin; Anti-Bacterial Agents; Escherichia coli; Female; Fosfomycin; Humans; Imipenem; Klebsiella pneumoniae; Linezolid; Male; Meropenem; Pseudomonas aeruginosa; Risk Factors; Tertiary Care Centers; Urinary Tract Infections; Vancomycin | 2022 |
ENDOPHTHALMITIS IN OPHTHALMOLOGICAL REFERRAL CENTRE IN COLOMBIA: AETIOLOGY AND MICROBIAL RESISTANCE.
Topics: Adult; Anti-Bacterial Agents; Colombia; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Imipenem; Male; Moxifloxacin; Referral and Consultation; Retrospective Studies; Vancomycin | 2022 |
Epidemiology and antibiotic resistance of prosthetic joint infections according to time of occurrence, a 10-year study.
Topics: Anti-Bacterial Agents; Arthritis, Infectious; Cefotaxime; Coagulase; Drug Resistance, Microbial; Gram-Negative Bacteria; Humans; Imipenem; Microbial Sensitivity Tests; Piperacillin; Prosthesis-Related Infections; Retrospective Studies; Staphylococcus aureus; Tazobactam; Vancomycin | 2022 |
Microbiological and Antibiotic Sensitivity Profile of Postoperative Endophthalmitis in a Tertiary Eye Care Hospital of North India.
Topics: Agar; Aged; Anti-Bacterial Agents; Endophthalmitis; Eye Infections, Bacterial; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Postoperative Complications; Retrospective Studies; Tertiary Care Centers; Vancomycin; Vitrectomy | 2021 |
A UPLC-MS/MS method for simultaneous determination of eight special-grade antimicrobials in human plasma and application in TDM.
Topics: Anti-Infective Agents; Chromatography, High Pressure Liquid; Chromatography, Liquid; Critical Illness; Drug Monitoring; Humans; Imipenem; Linezolid; Meropenem; Micafungin; Reproducibility of Results; Tandem Mass Spectrometry; Teicoplanin; Tigecycline; Vancomycin; Voriconazole | 2022 |
Japan perspective on antimicrobial stewardship and solid organ transplantation.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antimicrobial Stewardship; Escherichia coli; Humans; Imipenem; Japan; Organ Transplantation; Vancomycin | 2022 |
A 12-Year Retrospective Analysis of Blood Culture Isolates in the Intensive Care Unit of a Tertiary Hospital in China.
Topics: Amikacin; Anti-Bacterial Agents; Blood Culture; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Intensive Care Units; Linezolid; Meropenem; Microbial Sensitivity Tests; Retrospective Studies; Sepsis; Teicoplanin; Tertiary Care Centers; Vancomycin | 2023 |
In vitro activity of fidaxomicin and combinations of fidaxomicin with other antibiotics against Clostridium perfringens strains isolated from dogs and cats.
Topics: Animals; Anti-Bacterial Agents; Cat Diseases; Cats; Clindamycin; Clostridioides difficile; Clostridium Infections; Clostridium perfringens; Diarrhea; Dog Diseases; Dogs; Erythromycin; Fidaxomicin; Humans; Imipenem; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Vancomycin | 2023 |